Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3039429	sa-korsol	nmol/l (nmol/l)	1877	3029	0.69%
3039429	sa-korsol	— (—)	540	693	100.00%	Distribution not available
3039429	sa-korsol	nmol/L (nmol/l)	53	60	0.00%
3039429	sa-korsol	NMOL/L (nmol/l)	11	16	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Disorders of other endocrine glands

606

884

6.89

307.65

2.2

1.4

5.91

11.76

nmol/l

0.41

523

714

Benign neoplasm: Adrenal gland

506

121

49.51

307.65

1.9

1.6

4.75

4.23

nmol/l

0.09

448

Benign neoplasm of other and unspecified endocrine glands

665

216

34.58

307.65

2.1

1.5

4.33

3.92

nmol/l

0.10

584

166

Exclusions for E4_PCOS_BROAD

403

343

12.28

307.65

2.6

1.4

6.44

4.38

nmol/l

0.50

346

262

Cushing syndrome

149

124.94

291.34

4.3

1.3

11.31

1.42

nmol/l

2.80

143

Non-invasive ventilation

312

259

10.60

262.55

1.7

1.8

3.64

3.13

nmol/l

0.17

257

213

Endocrine, nutritional and metabolic diseases

539

505

5.43

203.88

1.7

1.4

9.26

2.26

nmol/l

0.88

436

409

Benign neoplasm: Pituitary gland, craniopharyngeal duct

167

100

18.01

202.91

2.8

1.7

3.00

3.98

nmol/l

0.20

143

Hypertension, essential

574

714

4.58

192.67

1.7

1.5

18.23

3.07

nmol/l

0.86

470

575

Hypertensive diseases (excluding secondary)

456

493

5.44

185.14

1.7

1.5

21.56

3.04

nmol/l

0.82

372

394

Hypertensive diseases

567

747

4.32

177.65

1.7

1.5

18.14

2.98

nmol/l

0.85

465

601

Hypertension

567

747

4.32

177.61

1.7

1.5

18.14

2.98

nmol/l

0.85

465

601

Hypokalaemia

184

186

10.18

161.95

1.7

1.6

10.94

6.06

nmol/l

0.70

158

145

Other disorders of fluid, electrolyte and acid-base balance

288

464

5.93

156.38

1.8

1.6

9.29

8.96

nmol/l

0.02

243

372

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

353

746

4.81

154.94

2.2

1.6

4.02

7.88

nmol/l

0.58

299

609

Other nutritional deficiencies

541

1494

3.34

140.46

1.7

1.6

3.88

8.58

nmol/l

0.62

436

1237

Obesity and other hyperalimentation

512

1463

3.32

132.87

1.7

1.6

3.89

8.70

nmol/l

0.63

409

1218

Obesity

508

1458

3.31

131.27

1.7

1.6

3.92

8.74

nmol/l

0.63

405

1213

Metabolic disorders

622

1193

3.15

130.02

1.7

1.6

13.46

5.02

nmol/l

0.49

529

973

Hyperaldosteronism

25.68

129.95

1.7

1.5

3.34

1.42

nmol/l

0.89

Obesity due to excess calories

409

1134

3.65

124.63

1.6

1.7

3.44

10.22

nmol/l

0.72

323

949

Antihypertensive medication - note that there are other indications

411

539

4.01

114.55

1.7

1.6

3.94

2.13

nmol/l

1.09

325

424

Benign neoplasms

580

1074

2.95

106.02

1.8

1.4

4.79

10.85

nmol/l

0.55

483

861

Cardiovascular diseases (excluding rheumatic etc)

434

714

3.50

104.82

1.7

1.6

16.57

2.55

nmol/l

0.58

349

571

Type 2 diabetes

613

1281

2.79

103.28

1.7

1.6

16.73

3.23

nmol/l

0.84

517

1048

Hypothyroidism (congenital or acquired)

183

126

8.21

102.26

1.8

1.4

5.55

1.48

nmol/l

1.71

149

Hypopituitarism

114

115

10.24

100.58

2.2

1.5

4.98

1.67

nmol/l

1.29

Diabetes mellitus

630

1359

2.69

99.64

1.7

1.6

16.28

3.13

nmol/l

0.85

534

1110

Malaise and fatigue

355

788

3.57

98.45

1.6

7.65

13.01

nmol/l

0.33

277

661

Hypothyroidism and >3 levothyroxin purchases

178

125

8.05

98.27

1.8

1.4

5.70

1.49

nmol/l

1.71

144

Hypothyroidism, levothyroxine purchases

178

125

8.05

98.27

1.8

1.4

5.70

1.49

nmol/l

1.71

144

Diabetes, varying definitions

625

1360

2.68

98.11

1.7

1.6

16.48

3.11

nmol/l

0.85

528

1112

Type 2 diabetes, wide definition

470

967

3.08

96.89

1.7

1.6

20.42

3.38

nmol/l

0.83

405

802

Diabetes medication

630

1433

2.58

92.37

1.7

1.6

16.15

3.22

nmol/l

0.82

533

1171

Exclusions for E4_PCOS_CONSORTIUM

517

1147

2.83

91.91

2.2

1.4

5.47

9.63

nmol/l

0.37

435

926

Secondary hypertension

12.03

90.26

1.9

1.7

6.87

2.11

nmol/l

0.97

Other (not insulin) diabetes medications

588

1316

2.64

89.96

1.7

1.6

16.60

3.33

nmol/l

0.78

498

1083

Abnormalities of breathing

543

1131

2.76

89.82

1.6

2.96

6.37

nmol/l

0.89

433

940

Anaemias

149

121

7.96

88.06

1.5

5.61

1.53

nmol/l

1.25

127

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

550

1222

2.68

87.38

1.7

1.6

17.62

3.29

nmol/l

0.80

472

1003

Type 2 diabetes, definitions combined

551

1221

2.64

84.33

1.7

1.6

18.07

3.24

nmol/l

0.83

466

1007

Type 2 diabetes, strict (exclude DM1)

552

1229

2.63

83.73

1.7

1.6

18.07

3.34

nmol/l

0.82

466

1015

Cardiovascular diseases

383

625

3.27

81.70

1.7

1.6

4.11

2.45

nmol/l

0.88

306

495

Sleep apnoea, including avohilmo

580

1404

2.51

81.40

1.6

12.62

5.68

nmol/l

0.33

465

1180

Type 2 diabetes, definitions combined, including avohilmo

547

1230

2.58

80.27

1.7

1.6

18.14

3.30

nmol/l

0.82

464

1012

Sleep apnoea

546

1380

2.51

77.35

1.7

1.6

13.15

5.79

nmol/l

0.34

442

1157

Disorders of lipoprotein metabolism and other lipidaemias

438

949

2.82

76.90

1.7

1.6

16.13

5.63

nmol/l

0.42

376

771

Biguanides

545

1315

2.51

76.77

1.7

1.6

17.67

3.36

nmol/l

0.80

470

1087

Diabetes, insulin treatment (Kela reimbursement)

565

1382

2.44

74.80

1.7

1.6

17.27

3.54

nmol/l

0.79

486

1132

Used for control exclusion in common control thyroid runs

556

1136

2.48

72.07

1.8

1.5

3.46

10.64

nmol/l

0.79

447

937

Other disorders of adrenal gland

10.80

71.31

2.6

1.5

7.10

1.68

nmol/l

2.48

General symptoms and signs

579

1215

2.40

69.96

1.7

1.6

4.51

9.12

nmol/l

0.47

476

1015

Depression medications

157

128

6.21

67.14

1.7

1.4

2.52

1.44

nmol/l

0.67

116

100

Diseases of arteries, arterioles and capillaries (FINNGEN)

137

160

5.96

66.14

1.8

1.6

6.09

2.28

nmol/l

0.70

118

127

Osteoporosis

192

447

3.99

65.26

1.8

1.6

4.92

5.52

nmol/l

0.13

172

373

Obesity, other/unspecified

253

784

3.26

65.09

1.8

1.6

3.09

13.61

nmol/l

0.81

199

652

Osteopathies and chondropathies

347

1169

2.73

64.07

1.7

1.6

4.23

5.65

nmol/l

0.27

300

964

Pure hypercholesterolaemia

374

887

2.69

61.19

1.7

1.6

18.37

5.71

nmol/l

0.44

322

721

Codeine

499

1155

2.34

58.98

1.6

13.83

5.68

nmol/l

0.35

412

948

Neoplasms

402

810

2.61

58.81

1.8

1.5

5.14

12.68

nmol/l

0.49

328

635

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

205

595

3.48

58.61

1.8

1.7

2.33

4.05

nmol/l

1.12

169

494

Glucagon-like peptide-1 (GLP-1) analogues

205

595

3.48

58.61

1.8

1.7

2.33

4.05

nmol/l

1.12

169

494

Symptoms and signs involving the circulatory and respiratory systems

521

1132

2.32

58.57

1.6

13.69

6.37

nmol/l

0.31

424

940

Heart failure, not strict

380

996

2.58

58.18

1.7

6.33

5.93

nmol/l

0.05

317

838

Headache

376

1154

2.53

57.49

1.7

1.6

3.68

9.50

nmol/l

0.60

298

960

Tramadol

419

1023

2.47

57.26

1.8

1.6

16.58

6.19

nmol/l

0.39

352

849

Mood disorders, excluding more controls

498

1298

2.26

55.79

1.6

13.98

5.89

nmol/l

0.34

405

1079

Episodal and paroxysmal disorders

546

1256

2.21

55.65

1.6

13.16

5.72

nmol/l

0.34

444

1038

Insulin medication

307

938

2.73

55.55

1.6

12.40

3.53

nmol/l

0.63

266

770

Heart failure and antihypertensive medication

119

132

5.90

55.47

1.7

6.77

2.49

nmol/l

1.11

102

Opioids

513

1182

2.25

54.63

1.7

1.6

13.80

5.87

nmol/l

0.35

428

971

Medical observation and evaluation for suspected diseases and conditions

332

611

2.79

54.26

1.9

1.5

12.13

4.81

nmol/l

0.49

271

503

Dyspnoea

478

1568

2.21

53.27

1.6

3.10

8.52

nmol/l

0.85

382

1314

Care involving use of rehabilitation procedures

364

1358

2.42

52.61

1.8

1.6

5.47

5.18

nmol/l

0.05

304

1125

Hypogonadotropic hypogonadism

12.25

52.59

1.9

1.3

5.55

1.57

nmol/l

0.61

Codeine or tramadol medication

583

1528

2.08

52.07

1.6

12.25

5.38

nmol/l

0.34

483

1265

Disorders of the thyroid gland

491

1474

2.17

51.04

1.7

1.6

3.73

9.03

nmol/l

0.74

404

1228

Neurological diseases, wide definition

165

190

4.39

50.61

1.6

3.84

3.01

nmol/l

0.18

127

154

Mood disorders

544

1686

2.07

50.12

1.6

13.06

5.29

nmol/l

0.36

439

1409

Pain in throat and chest

425

1094

2.31

49.98

1.8

1.6

14.95

6.52

nmol/l

0.29

346

912

Mood [affective] disorders

543

1687

2.07

49.96

1.6

13.08

5.29

nmol/l

0.36

438

1410

Depression

518

1659

2.10

49.76

1.6

13.80

5.28

nmol/l

0.37

414

1385

Insulin, intermediate and long-acting

288

1076

2.60

48.96

1.6

12.96

4.35

nmol/l

0.56

251

888

Other heart diseases

232

492

3.08

48.66

1.7

1.5

27.72

3.08

nmol/l

0.55

191

391

Sleep disorders (combined)

529

1322

2.10

47.83

1.6

3.22

6.11

nmol/l

0.85

435

1104

Any reimbursement code in KELA

310

581

2.69

47.13

1.6

3.12

2.16

nmol/l

0.54

251

461

Neurological diseases

411

894

2.32

46.50

1.6

3.45

6.58

nmol/l

0.56

328

739

Any gastric operation

383

806

2.39

46.42

1.8

1.6

5.25

12.17

nmol/l

0.44

312

644

GASTRO-related operations

383

806

2.39

46.42

1.8

1.6

5.25

12.17

nmol/l

0.44

312

644

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

338

1246

2.37

46.38

1.7

1.6

4.87

5.83

nmol/l

0.18

281

1047

Implicit Sepsis

382

1240

2.28

46.15

1.7

1.6

3.78

9.94

nmol/l

0.73

314

1033

Hypothyroidism, other/unspecified

456

1410

2.13

45.78

1.8

1.6

3.72

9.31

nmol/l

0.75

378

1173

Hypothyreosis and Thyroxine purchase for inclusion criteria

479

1516

2.08

44.84

1.8

1.6

3.60

8.83

nmol/l

0.75

397

1256

Pain in joint

298

714

2.57

44.64

1.7

3.27

7.51

nmol/l

0.66

249

597

Insulin, combination of fast acting with intermediate-acting or long-acting

307

1158

2.42

44.32

1.6

12.40

4.16

nmol/l

0.57

266

956

Postprocedural endocrine and metabolic disorders, not elsewhere classified

102

219

4.72

44.27

2.2

1.6

6.34

4.82

nmol/l

0.21

163

Abnormalities of heart beat

200

656

2.97

44.12

1.6

3.67

8.49

nmol/l

0.68

157

552

Recurrent or chronic depression

230

557

2.88

43.95

1.5

1.7

1.93

8.34

nmol/l

0.89

167

476

Disorders of thyroid, IBD co-morbidities

127

5.37

43.29

1.7

3.61

3.85

nmol/l

0.03

103

Hirsutism in women

11.27

42.97

1.8

1.9

1.38

2.05

nmol/l

0.54

Statin medication

353

849

2.35

42.71

1.7

1.6

19.33

2.90

nmol/l

0.58

297

674

Cerebrovascular diseases (FINNGEN)

145

269

3.80

42.67

1.8

1.6

3.63

1.89

nmol/l

1.39

121

214

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

459

1507

2.06

42.55

1.7

1.6

14.86

5.25

nmol/l

0.40

386

1247

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

171

234

3.68

42.53

1.7

1.5

4.07

11.70

nmol/l

0.35

135

197

Anxiety disorders, excluding more controls

422

1264

2.14

42.48

1.5

1.6

15.50

5.88

nmol/l

0.33

330

1049

Low back pain

404

1268

2.16

42.09

1.5

1.6

3.54

5.59

nmol/l

0.49

318

1053

Hypothyroidism, drug reimbursement

7.34

41.46

1.7

1.5

3.10

1.75

nmol/l

0.41

Disorders of parathyroid gland

128

339

3.77

41.26

1.9

1.5

5.24

4.21

nmol/l

0.19

108

275

Other metabolic disorders

103

237

4.40

41.03

2.2

1.6

6.34

4.58

nmol/l

0.26

178

Implicit Sepsis, including avohilmo

403

1373

2.10

39.91

1.7

1.6

3.82

9.36

nmol/l

0.72

330

1143

Other antidepressants

471

1180

2.04

39.75

1.6

2.83

6.06

nmol/l

0.91

387

1002

Cardiac arrhythmias

296

786

2.42

39.73

1.6

1.7

21.48

3.46

nmol/l

0.50

241

629

Psychiatric diseases

447

1082

2.08

39.08

1.6

4.27

6.46

nmol/l

0.41

360

905

Other soft tissue disorders, not elsewhere classified

467

1324

2.01

38.96

1.6

1.7

3.21

9.67

nmol/l

0.83

389

1090

Hypertrichosis

9.46

38.90

1.9

1.8

1.36

6.03

nmol/l

0.57

Parasetamol

341

750

2.31

38.42

1.7

1.6

3.71

7.24

nmol/l

0.53

276

613

Anxiety (asthma-related co-morbidities)

342

1192

2.19

38.00

1.6

18.31

5.73

nmol/l

0.36

273

977

Condition for Implicit Sepsis (Organ dysfunction codes)

415

1410

2.05

37.95

1.7

1.6

3.73

9.16

nmol/l

0.72

344

1170

Asthma, excluding more controls

366

855

2.21

37.42

1.6

2.53

11.55

nmol/l

0.75

295

717

Dorsalgia

481

1295

1.97

37.39

1.6

1.7

3.55

5.67

nmol/l

0.53

393

1075

Osteoporosis with pathological fracture (FG)

112

6.00

37.30

1.5

1.8

3.97

5.44

nmol/l

0.29

Anxiety disorders

468

1657

1.94

37.07

1.5

1.7

14.12

5.47

nmol/l

0.33

369

1385

Persons encountering health services for specific procedures and health care

529

1665

1.88

36.72

1.8

1.6

15.46

4.61

nmol/l

0.55

440

1372

Other functional intestinal disorders

236

867

2.48

36.37

1.6

1.7

3.65

6.88

nmol/l

0.58

196

720

Lower back pain or/and sciatica

528

1763

1.87

36.29

1.6

3.08

8.09

nmol/l

0.88

426

1471

Hypertensive heart and/or renal disease

107

188

4.18

36.27

1.6

1.5

5.81

3.28

nmol/l

0.75

154

Oedema, not elsewhere classified

166

553

2.95

36.25

1.8

1.6

5.03

7.74

nmol/l

0.26

128

468

Neurotic, stress-related and somatoform disorders

462

1654

1.93

35.91

1.5

1.7

14.22

5.47

nmol/l

0.33

366

1380

Personality disorders, excluding more controls

159

536

2.98

35.53

1.6

36.75

7.87

nmol/l

0.39

127

429

Hyperparathyroidism

108

283

3.81

35.46

2.0

1.5

5.31

4.61

nmol/l

0.10

231

Asthma

371

898

2.14

35.29

1.6

2.63

11.22

nmol/l

0.75

299

755

Asthma (only as main-diagnosis), excluding more controls

339

855

2.20

35.24

1.6

2.93

11.55

nmol/l

0.70

273

717

All anxiety disorders

353

1320

2.08

34.79

1.5

1.6

17.69

5.90

nmol/l

0.35

283

1090

Other diseases of intestines

509

1515

1.88

34.69

1.6

1.7

4.36

8.72

nmol/l

0.56

421

1246

Hyperfunction of pituitary gland

6.48

34.66

2.0

1.4

1.90

3.75

nmol/l

0.57

Diseases of oesophagus, stomach and duodenum

509

1616

1.86

34.50

1.6

4.21

8.27

nmol/l

0.58

420

1344

Obesity related asthma

202

787

2.58

34.44

1.7

3.46

7.44

nmol/l

0.64

166

659

Other anxiety disorders

282

1074

2.25

34.14

1.6

1.7

21.89

6.59

nmol/l

0.36

224

882

Symptoms and signs involving cognition, perception, emotional state and behaviour

467

1655

1.89

33.97

1.6

1.7

14.89

5.23

nmol/l

0.39

378

1387

Any mental disorder

493

1307

1.89

33.63

1.6

4.04

5.89

nmol/l

0.41

409

1085

Asthma (only as main-diagnosis)

343

898

2.14

33.59

1.6

2.94

11.22

nmol/l

0.71

276

755

Symptoms and signs involving the nervous and musculoskeletal systems

293

1364

2.16

33.20

1.6

3.41

9.42

nmol/l

0.79

237

1139

Asthma (mode)

362

909

2.10

33.11

1.6

2.28

11.12

nmol/l

0.80

293

763

Benzodiazepine use

486

1779

1.85

33.09

1.5

1.7

3.19

7.99

nmol/l

0.84

396

1482

Asthma, unspecified (mode), excluding more controls

259

800

2.33

32.80

1.7

1.6

2.21

12.20

nmol/l

0.80

220

672

Nerve, nerve root and plexus disorders

498

1628

1.84

32.67

1.6

13.73

5.27

nmol/l

0.38

420

1348

Dipeptidyl peptidase 4 (DPP-4) inhibitors

226

731

2.43

32.35

1.7

1.6

4.78

3.90

nmol/l

0.27

187

614

Abnormal findings on examination of blood, without diagnosis

223

840

2.41

32.33

1.7

5.93

7.39

nmol/l

0.17

187

694

Ovarian dysfunction

171

4.58

32.21

1.9

1.4

1.10

2.56

nmol/l

0.99

121

Percutaneous Coronary Intervention

351

1035

2.07

32.20

1.7

18.05

6.53

nmol/l

0.37

301

860

Pain in limb

399

1297

1.96

31.96

1.6

1.7

3.37

9.75

nmol/l

0.79

338

1071

Hyperprolactinaemia

7.71

31.95

1.4

1.76

1.71

nmol/l

0.03

Asthma, unspecified (mode)

263

838

2.27

31.72

1.7

1.6

2.20

11.89

nmol/l

0.82

223

705

Atrial fibrillation and flutter

123

227

3.51

31.71

1.6

42.89

1.99

nmol/l

0.51

108

179

Hypothyroidism, strict autoimmune

327

1029

2.09

31.48

1.5

3.05

11.56

nmol/l

0.87

266

850

Polycystic ovarian syndrome

124

5.26

31.47

1.8

1.4

0.98

1.53

nmol/l

1.18

Coronary revascularization (ANGIO or CABG)

349

1036

2.05

31.37

1.7

18.09

6.52

nmol/l

0.36

299

861

Other dorsopathies, not elsewhere classified

467

1296

1.88

31.34

1.6

1.7

4.09

5.67

nmol/l

0.35

377

1075

Atrial fibrillation and flutter with reimbursement

153

4.10

31.08

1.6

1.5

54.54

2.19

nmol/l

0.50

121

Migraine

271

960

2.21

30.95

1.5

1.7

3.02

6.18

nmol/l

0.61

213

793

Ischemic heart diseases

365

1087

2.01

30.67

1.7

1.6

17.47

6.27

nmol/l

0.37

312

903

Other special examinations and investigations of persons without complaint or reported diagnosis

275

611

2.29

30.60

1.6

1.5

4.31

4.81

nmol/l

0.13

216

503

Hard cardiovascular diseases

375

1121

1.98

30.50

1.6

17.28

6.24

nmol/l

0.37

317

932

Concussion

222

723

2.39

30.50

1.6

27.66

7.28

nmol/l

0.39

177

604

All chronic kidney diseases

245

863

2.27

30.22

1.7

5.40

6.07

nmol/l

0.08

218

712

Other headache syndromes

215

917

2.35

29.93

1.5

1.6

3.31

6.57

nmol/l

0.58

177

764

Intracranial trauma

249

740

2.28

29.82

1.6

24.24

7.12

nmol/l

0.37

202

619

Other symptoms and signs involving the nervous and musculoskeletal systems

225

987

2.29

29.61

1.6

3.83

11.68

nmol/l

0.73

182

815

First line medication for Crohn's disease

510

1544

1.78

29.35

1.8

1.5

14.86

4.74

nmol/l

0.48

420

1283

Fibromyalgia

219

3.94

29.28

1.6

1.7

1.65

3.77

nmol/l

1.48

168

Primary hyperparathyroidism

228

3.87

29.26

2.0

1.8

4.57

5.84

nmol/l

0.17

187

Other intervertebral disc disorders

374

1146

1.95

29.19

1.6

17.57

6.01

nmol/l

0.39

313

959

Depression or dysthymia

283

709

2.19

29.06

1.6

4.56

7.92

nmol/l

0.43

211

609

Emergency coronary revascularization (for ACS)

362

1114

1.97

29.01

1.7

1.6

17.58

6.26

nmol/l

0.37

310

932

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

455

1703

1.81

28.81

1.7

1.6

5.13

7.79

nmol/l

0.34

387

1399

Hypo-osmolality and hyponatraemia

251

3.66

28.73

1.9

1.6

8.42

4.88

nmol/l

0.55

208

Chronic lower respiratory diseases

551

1689

1.72

28.14

1.6

1.7

3.32

8.38

nmol/l

0.84

448

1404

Postmenopausal osteoporosis with pathological fracture

118

5.09

28.01

1.5

1.8

3.92

6.14

nmol/l

0.44

Major coronary heart disease event

359

1105

1.95

27.98

1.7

1.6

17.65

6.28

nmol/l

0.37

308

923

Disorders of continuity of bone

201

3.98

27.69

1.8

1.6

2.04

2.80

nmol/l

0.52

147

Spondylopathies

332

990

1.99

27.32

1.7

1.6

4.00

6.50

nmol/l

0.46

276

831

Other specific joint derangements/joint disorders

372

1222

1.90

27.31

1.6

1.7

2.95

9.82

nmol/l

0.83

311

1011

All kidney diseases

459

1742

1.77

27.20

1.6

5.54

7.52

nmol/l

0.23

395

1425

Hypertensive Heart Disease

173

3.83

26.82

1.7

1.5

6.66

3.40

nmol/l

0.83

143

STROKE

231

699

2.23

26.38

1.7

1.6

4.09

3.52

nmol/l

0.24

197

575

Hyperhidrosis

7.47

26.36

2.1

1.9

1.11

2.95

nmol/l

0.94

Gastro-oesophageal reflux disease

313

1359

1.95

26.28

1.5

1.6

2.40

9.20

nmol/l

0.96

258

1133

Complications of surgical and medical care, not elsewhere classified

454

1730

1.75

26.17

1.7

1.6

3.78

7.93

nmol/l

0.65

369

1446

Complications of medical and surgical care

342

1645

1.87

25.82

1.6

4.67

8.12

nmol/l

0.47

282

1371

Other heart diseases, wide

432

1470

1.78

25.73

1.6

17.50

5.04

nmol/l

0.50

352

1211

Nonorganic sleeping disorders, excluding more controls

123

433

2.86

25.70

1.4

1.7

3.41

3.93

nmol/l

0.13

348

Cervical disc disorders

166

680

2.45

25.60

1.5

1.6

2.17

7.89

nmol/l

0.96

130

576

Renal failure

197

731

2.30

25.58

1.6

5.35

8.35

nmol/l

0.41

172

616

Spinal stenosis

206

666

2.29

25.48

1.8

1.6

3.94

8.15

nmol/l

0.59

172

570

Nausea and vomiting

145

543

2.62

25.46

1.5

1.7

6.40

3.51

nmol/l

0.78

116

450

Asthma (diagnoses ohter than nonallergic)

408

1860

1.78

25.44

1.6

2.92

8.06

nmol/l

0.97

333

1538

Insulin, fast-acting

177

749

2.37

25.37

1.5

1.7

6.59

4.81

nmol/l

0.39

153

606

Autoimmune diseases

486

1430

1.73

25.04

1.7

1.6

3.62

9.15

nmol/l

0.75

398

1183

Dizziness and giddiness

336

1395

1.88

24.93

1.5

1.6

19.34

5.57

nmol/l

0.41

276

1177

Non-selective monoamine reuptake inhibitors

172

698

2.38

24.53

1.7

1.6

2.68

7.85

nmol/l

0.88

133

595

Sciatica+with lumbago

241

1031

2.08

24.42

1.6

2.65

6.20

nmol/l

0.86

205

869

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

408

1340

1.78

24.21

1.7

1.6

4.87

9.28

nmol/l

0.50

343

1127

408

1340

1.78

24.21

1.7

1.6

4.87

9.28

nmol/l

0.50

343

1127

Examination and observation for other reasons

235

611

2.18

24.20

1.6

1.5

23.39

4.81

nmol/l

0.43

211

503

Hyperlipidaemia, other/unspecified

146

515

2.56

24.10

1.5

1.6

2.73

8.38

nmol/l

0.63

128

425

Complications of procedures, not elsewhere classified

369

1656

1.80

24.07

1.6

3.15

8.18

nmol/l

0.83

297

1392

Selective serotonin reuptake inhibitors

409

1188

1.79

24.04

1.7

1.6

4.46

6.03

nmol/l

0.29

316

1007

Insulin, fast-acting or short human

180

792

2.28

23.62

1.5

1.7

6.56

7.61

nmol/l

0.11

154

642

Abdominal and pelvic pain

408

1151

1.78

23.37

1.6

1.7

4.41

5.36

nmol/l

0.16

332

951

Other pulmonary diagnosis

340

905

1.89

23.20

1.6

4.10

11.15

nmol/l

0.58

270

761

Visual disturbances

237

1172

2.03

23.13

1.5

1.6

3.73

10.85

nmol/l

0.80

191

980

Soft tissue disorders

447

1328

1.73

23.09

1.6

1.7

3.78

9.65

nmol/l

0.71

369

1093

Symptoms and signs concerning food and fluid intake

164

3.99

23.00

1.9

1.6

9.04

6.21

nmol/l

0.17

132

Disturbances of skin sensation

162

690

2.36

23.00

1.5

1.7

3.30

15.76

nmol/l

0.85

126

570

Symptoms and signs involving the digestive system and abdomen

407

1151

1.78

22.97

1.6

1.7

5.18

5.36

nmol/l

0.02

331

951

Asthma, including avohilmo

521

1747

1.65

22.90

1.6

1.7

13.00

5.40

nmol/l

0.33

418

1457

Visual disturbances and blindness

247

1243

1.99

22.87

1.5

1.6

3.63

10.44

nmol/l

0.82

199

1035

Renal tubulo-interstitial diseases

387

1619

1.76

22.85

1.6

5.24

7.87

nmol/l

0.31

332

1334

Polycystic ovarian syndrome, consortium definition

376

1205

1.80

22.72

1.8

1.6

1.89

7.63

nmol/l

0.71

304

987

Abnormal findings on diagnostic imaging of other body structures

285

3.19

22.72

1.6

1.7

5.92

6.05

nmol/l

0.02

232

Syncope and collapse

185

689

2.25

22.69

1.6

5.76

6.62

nmol/l

0.09

155

582

Ischaemic heart disease, wide definition

304

982

1.91

22.66

1.6

1.7

20.68

6.55

nmol/l

0.40

262

819

Caries of dentine

120

429

2.71

22.60

1.7

1.6

5.74

10.06

nmol/l

0.34

360

Diseases of arteries, arterioles and capillaries

262

972

1.98

22.58

1.7

1.6

6.30

6.47

nmol/l

0.02

224

809

Coronary atherosclerosis

249

774

2.04

22.30

1.5

1.6

23.99

7.96

nmol/l

0.36

214

649

General examination and investigation of persons without complaint and reported diagnosis

245

611

2.09

22.30

1.6

1.5

22.95

4.81

nmol/l

0.41

208

503

Dental caries

128

465

2.61

22.27

1.7

1.6

5.50

9.48

nmol/l

0.34

101

388

Disorders of mineral metabolism

134

4.30

22.26

1.3

1.7

3.04

6.69

nmol/l

0.51

106

Pain (limb, back, neck, head abdominally)

284

721

1.98

22.22

1.6

1.7

4.80

7.45

nmol/l

0.32

221

603

Mouth breathing

187

861

2.18

21.97

1.7

2.57

7.59

nmol/l

1.05

156

703

Excluding asthma or asthma-COPD overlap

335

905

1.86

21.90

1.6

5.44

11.15

nmol/l

0.42

265

761

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

271

1403

1.90

21.78

1.7

1.6

4.12

9.07

nmol/l

0.63

221

1173

Personality disorders

159

689

2.32

21.74

1.6

36.75

6.87

nmol/l

0.41

127

564

Irritable bowel syndrome

148

622

2.39

21.68

1.4

1.8

2.98

4.07

nmol/l

0.30

118

505

Infections, IBD-co-morbidities

4.35

21.60

1.9

1.5

4.42

4.72

nmol/l

0.04

Type 1 diabetes

121

464

2.62

21.45

1.4

1.7

4.03

3.82

nmol/l

0.04

365

Use of hypnotics and sedatives

458

1574

1.67

21.36

1.6

1.7

15.92

5.07

nmol/l

0.46

380

1312

Other CVD (FINNGEN)

5.08

21.33

1.6

1.4

9.72

1.82

nmol/l

0.97

Disorders of skin appendages

255

1324

1.92

21.32

1.7

1.6

21.59

5.80

nmol/l

0.37

221

1077

Persons encountering health services for examination and investigation

246

611

2.02

20.53

1.7

1.5

3.90

4.81

nmol/l

0.26

194

503

Early onset COPD, excluding more controls

313

2.95

20.50

1.6

1.8

5.73

10.65

nmol/l

0.27

262

Abnormal findings on diagnostic imaging of lung

187

837

2.12

20.45

1.6

5.68

7.53

nmol/l

0.24

163

716

Implicit bacterial Sepsis, including avohilmo

183

707

2.16

20.39

1.8

1.6

4.49

8.37

nmol/l

0.57

154

593

COPD differential diagnosis

330

910

1.82

20.29

1.6

5.52

11.11

nmol/l

0.41

261

764

Dorsopathies

432

1304

1.68

20.27

1.6

3.51

5.65

nmol/l

0.53

352

1080

Gastrointestinal diseases

264

676

1.96

20.26

1.7

5.36

6.40

nmol/l

0.10

214

550

Other and unspecified nerve root and plexus disorders, also in other diseases

115

444

2.61

20.23

1.5

1.7

52.88

11.27

nmol/l

0.42

358

Implicit viral Sepsis, including avohilmo

141

597

2.37

20.23

1.8

1.6

4.30

9.15

nmol/l

0.58

116

488

Paroxysmal tachycardia

243

3.06

20.14

1.6

1.7

6.40

1.82

nmol/l

1.02

192

Symptoms and signs involving the urinary system

315

1329

1.79

20.14

1.5

1.7

6.21

9.27

nmol/l

0.29

256

1104

ILD differential diagnosis

329

909

1.82

20.11

1.6

5.52

11.12

nmol/l

0.41

261

763

Irregular menses

265

1057

1.89

20.03

1.9

1.6

1.75

8.00

nmol/l

0.67

218

862

Bacterial Sepsis

189

740

2.12

20.03

1.7

1.6

3.55

8.12

nmol/l

0.76

161

616

Behavioural syndromes associated with physiological disturbances and physical factors

418

1707

1.66

19.95

1.6

1.7

15.44

5.48

nmol/l

0.36

342

1414

Constipation

379

1510

1.70

19.95

1.5

1.7

3.57

8.77

nmol/l

0.76

302

1271

Pain, not elsewhere classified

131

542

2.43

19.90

1.9

1.6

4.64

17.42

nmol/l

0.64

110

455

Other neurological diseases

292

1247

1.82

19.78

1.6

4.83

5.97

nmol/l

0.22

248

1048

Implicit bacterial Sepsis

165

640

2.22

19.76

1.8

1.6

3.87

9.06

nmol/l

0.75

139

539

Hernia of abdominal wall, postoperative

250

3.15

19.72

1.7

1.6

4.62

11.68

nmol/l

0.33

203

Spondylosis

216

844

2.01

19.58

1.5

1.6

3.89

7.08

nmol/l

0.52

180

718

Iron deficiency anaemia

190

904

2.07

19.55

1.5

1.6

4.63

4.54

nmol/l

0.02

160

749

Specific personality disorders

140

603

2.34

19.48

1.5

1.7

40.96

7.47

nmol/l

0.41

113

488

Asthma, hospital admissions , main diagnosis only

366

1890

1.69

19.47

1.6

3.29

7.89

nmol/l

0.83

294

1565

Other and unspecified iron deficiency

161

734

2.20

19.43

1.5

1.6

4.92

4.68

nmol/l

0.05

137

602

Asthma/COPD (KELA code 203)

416

1687

1.65

19.42

1.5

1.7

3.25

8.39

nmol/l

0.85

335

1403

Other diseases of liver

105

396

2.67

19.39

1.8

1.7

2.48

5.58

nmol/l

1.43

320

Disorders of adult personality and behaviour

160

731

2.20

19.33

1.6

36.16

6.59

nmol/l

0.42

129

597

Nutritional anaemias

214

1037

1.97

19.24

1.5

1.6

5.76

6.74

nmol/l

0.14

182

860

Malignant neoplasm of endocrine gland, including Hilmo

168

3.68

19.24

1.7

1.9

8.50

6.04

nmol/l

0.42

130

Lumbar disc prolapse

271

1088

1.85

19.16

1.6

23.02

6.23

nmol/l

0.41

226

915

Somatoform disorder

359

2.75

19.16

1.6

1.7

2.99

5.43

nmol/l

0.53

294

Oxycodone

151

572

2.26

19.02

1.6

5.65

9.22

nmol/l

0.36

128

474

Shoulder lesions

312

1047

1.79

18.99

1.5

1.7

5.09

11.33

nmol/l

0.56

267

876

Asthma-related infections

264

1411

1.83

18.92

1.6

3.11

9.52

nmol/l

0.91

208

1171

Asthma, hospital admission 2, infections

264

1411

1.83

18.92

1.6

3.11

9.52

nmol/l

0.91

208

1171

Symptoms and signs involving the skin and subcutaneous tissue

324

1778

1.73

18.92

1.6

3.69

8.04

nmol/l

0.71

271

1473

Diseases of the respiratory system

270

716

1.89

18.78

1.6

4.46

13.81

nmol/l

0.62

211

608

Pneumonias (Asthma/COPD co-morbidities)

442

1795

1.61

18.67

1.7

1.6

4.94

7.69

nmol/l

0.38

371

1477

Malignant neoplasm of endocrine gland

144

3.87

18.66

1.7

1.9

8.97

6.81

nmol/l

0.31

110

Combinations of oral blood glucose lowering drugs

110

434

2.55

18.53

1.7

1.6

24.24

4.88

nmol/l

0.48

362

Hyperkinetic disorders, excluding more controls

272

2.94

18.48

1.5

1.7

3.29

2.80

nmol/l

0.08

209

Influenza and pneumonia

463

1798

1.59

18.40

1.7

1.6

4.66

7.77

nmol/l

0.45

387

1478

Autoimmune diseases excluding thyroid diseases

427

1419

1.63

18.36

1.8

1.6

3.60

9.21

nmol/l

0.76

356

1174

All pneumoniae

443

1801

1.60

18.23

1.7

1.6

4.93

7.67

nmol/l

0.38

372

1481

COPD

166

630

2.15

18.20

1.5

1.7

5.34

8.97

nmol/l

0.42

140

537

Other symptoms and signs involving cognitive functions and awareness

188

822

2.03

18.19

1.6

2.85

7.83

nmol/l

1.02

148

695

Brachial plexus disorders

199

3.35

18.15

1.6

1.8

3.15

3.34

nmol/l

0.05

151

Hypothyroidism, strict autoimmune, 3 medication purchases required

357

1428

1.68

18.01

1.5

1.6

2.94

9.20

nmol/l

0.89

292

1184

Genitourinary diseases

232

593

1.97

18.00

1.7

1.6

16.46

3.87

nmol/l

0.64

193

501

Chronic kidney disease

125

511

2.36

17.81

1.6

4.88

10.91

nmol/l

0.67

106

435

Other joint disorders

392

1235

1.66

17.72

1.6

3.27

9.90

nmol/l

0.79

320

1022

Vocal cord dysfunction

136

3.71

17.71

1.7

1.8

2.55

2.08

nmol/l

0.26

105

Other/unspecified dorsalgia

166

786

2.09

17.71

1.6

4.13

7.04

nmol/l

0.41

137

665

Sleep disorders

397

1683

1.63

17.69

1.6

15.99

5.52

nmol/l

0.37

329

1396

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

429

1792

1.60

17.58

1.7

1.6

5.02

7.71

nmol/l

0.36

361

1474

Certain infectious and parasitic diseases

421

1301

1.62

17.39

1.6

5.19

4.62

nmol/l

0.09

341

1074

Abnormal blood-pressure reading, without diagnosis

5.00

17.37

1.3

1.8

1.59

6.50

nmol/l

0.93

Heart failure,strict

186

638

2.04

17.32

1.7

1.6

8.07

7.93

nmol/l

0.01

151

554

Diseases of the skin and subcutaneous tissue

399

1221

1.64

17.25

1.7

1.6

2.79

6.19

nmol/l

0.99

326

1005

Diseases of liver

159

760

2.10

17.18

1.6

1.7

2.26

8.37

nmol/l

1.21

123

631

Epilepsy

128

560

2.29

17.07

1.4

1.7

2.73

8.96

nmol/l

0.79

111

459

COPD/asthma/ILD related infections

429

1340

1.61

16.99

1.6

3.39

9.28

nmol/l

0.75

343

1127

COPD/asthma related infections

429

1340

1.61

16.99

1.6

3.39

9.28

nmol/l

0.75

343

1127

209

1095

1.90

16.99

1.6

3.19

11.14

nmol/l

0.85

163

900

Insomnia

398

1725

1.61

16.96

1.6

1.7

15.75

5.43

nmol/l

0.36

332

1426

Falls/tendency to fall

457

1451

1.58

16.92

1.6

3.91

9.07

nmol/l

0.69

372

1215

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

133

514

2.27

16.90

1.5

1.6

2.54

2.59

nmol/l

0.01

102

402

Fever of other and unknown origin

217

1000

1.88

16.83

1.6

6.07

10.69

nmol/l

0.36

180

837

COPD (mode)

121

398

2.38

16.79

1.5

1.7

6.20

9.16

nmol/l

0.20

100

342

Implicit viral Sepsis

379

2.57

16.73

1.8

1.6

3.33

6.88

nmol/l

1.17

310

Viral Sepsis

380

2.57

16.65

1.8

1.6

3.33

6.87

nmol/l

1.16

311

Explicit Sepsis

172

778

2.02

16.47

1.8

1.6

3.53

7.82

nmol/l

0.74

148

645

Nonorganic sleeping disorders

123

540

2.29

16.46

1.4

1.7

3.41

4.09

nmol/l

0.19

435

Other bacterial diseases, including avohilmo

426

1689

1.58

16.41

1.7

1.6

5.53

7.75

nmol/l

0.27

355

1401

Other blood glucose lowering drugs, excl. Insulins

238

3.00

16.38

1.5

1.7

3.45

6.50

nmol/l

0.70

199

Elevated blood glucose level

168

3.43

16.28

1.4

1.9

4.48

8.05

nmol/l

0.51

139

Functional dyspepsia

133

606

2.21

16.27

1.7

2.85

3.98

nmol/l

0.48

114

498

Cerebrovascular diseases

272

1075

1.76

16.20

1.7

1.6

5.57

6.08

nmol/l

0.08

224

906

Oral corticosteroids

445

1678

1.56

16.05

1.6

3.51

8.28

nmol/l

0.77

355

1403

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

241

1353

1.78

16.00

1.7

1.6

4.23

9.58

nmol/l

0.66

193

1136

Diseases of the musculoskeletal system and connective tissue

223

587

1.91

15.99

1.7

1.6

5.04

7.29

nmol/l

0.20

181

470

Amenorrhoea

156

3.50

15.92

2.6

1.7

1.90

4.31

nmol/l

0.87

133

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

132

597

2.19

15.90

1.6

1.7

45.67

7.82

nmol/l

0.41

483

Dermatitis and eczema

468

1810

1.53

15.79

1.6

15.36

4.96

nmol/l

0.44

383

1499

Diarrhoea and gastroenteritis of presumed infectious origin

305

1635

1.67

15.75

1.7

1.6

21.28

5.30

nmol/l

0.44

250

1350

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

222

1180

1.82

15.71

1.8

1.6

4.48

10.50

nmol/l

0.65

166

1004

Other disorders of urethra and urinary system

299

1229

1.70

15.71

1.7

1.6

3.19

8.29

nmol/l

0.62

240

1029

Benign thyroid growths and nodules

140

612

2.13

15.60

1.7

1.6

3.71

4.84

nmol/l

0.34

110

511

Substance abuse, excluding more controls

210

948

1.86

15.48

1.6

28.17

7.06

nmol/l

0.39

173

785

Diseases of the eye and adnexa

342

1035

1.66

15.42

1.5

1.7

11.69

8.25

nmol/l

0.16

279

847

Intestinal infectious diseases

397

1887

1.57

15.41

1.7

1.6

17.38

5.00

nmol/l

0.44

323

1565

Peripheral artery disease

150

568

2.09

15.40

1.7

1.6

7.94

8.94

nmol/l

0.07

124

493

Finngen Rheumatological endpoints

404

1455

1.58

15.38

1.5

1.7

3.80

9.02

nmol/l

0.70

339

1205

Other chronic obstructive pulmonary disease

153

608

2.07

15.31

1.6

1.7

5.64

9.05

nmol/l

0.37

127

521

Type 1 diabetes, wide definition

102

426

2.40

15.28

1.5

1.7

4.32

3.82

nmol/l

0.08

335

332

2.61

15.27

1.7

1.8

3.19

4.50

nmol/l

0.34

267

Infections of the skin and subcutaneous tissue

256

1463

1.73

15.22

1.6

3.26

9.13

nmol/l

0.83

224

1202

Explicit Sepsis, including avohilmo

173

804

1.96

15.17

1.8

1.6

3.53

7.62

nmol/l

0.72

148

667

Fall on same level

482

1698

1.52

15.12

1.7

1.6

3.01

8.30

nmol/l

0.91

384

1420

Inflammatory bowel disease treatment related agents

474

1735

1.52

15.09

1.6

3.42

8.19

nmol/l

0.80

381

1448

Septicaemia

163

750

1.99

14.98

1.7

1.6

3.55

7.88

nmol/l

0.71

141

619

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

198

3.12

14.96

2.1

1.8

1.52

3.43

nmol/l

0.86

149

Pneumonia, organism unspecified

380

1657

1.58

14.90

1.7

1.6

5.44

8.01

nmol/l

0.31

323

1371

Migraine without aura

109

475

2.31

14.88

1.7

4.63

2.82

nmol/l

0.39

388

Atherosclerosis, excluding cerebral and coronary sclerosis

138

510

2.13

14.87

1.8

1.6

8.09

9.54

nmol/l

0.10

119

442

Disorder of lipoprotein metabolism, unspecified

173

3.26

14.86

2.1

1.6

7.44

6.06

nmol/l

0.11

143

Other chronic obstructive pulmonary disease, including avohilmo

190

827

1.89

14.84

1.6

4.94

7.54

nmol/l

0.38

160

701

Disorders of gallbladder, biliary tract and pancreas

394

1569

1.57

14.76

1.6

3.67

8.54

nmol/l

0.72

325

1317

Type 1 diabetes, wide definition, subgroup 1

409

2.41

14.72

1.5

1.7

4.47

3.82

nmol/l

0.11

317

Bleeding

315

1356

1.63

14.36

1.7

1.6

5.15

5.68

nmol/l

0.09

271

1122

Diverticular disease of intestine

250

894

1.74

14.25

1.6

1.7

3.57

6.71

nmol/l

0.59

211

753

Missing teeth due to accident, extraction or parodontitis

242

1258

1.72

14.11

1.8

1.6

25.14

5.97

nmol/l

0.43

202

1054

Certain infectious and parasitic diseases, including avohilmo

289

859

1.69

13.99

1.7

1.6

5.62

5.39

nmol/l

0.02

227

713

Haemorrhage from respiratory passages

121

497

2.16

13.87

1.9

1.6

5.79

10.61

nmol/l

0.43

101

411

Schizophrenia or delusion, excluding more controls

124

579

2.12

13.84

1.6

44.28

8.65

nmol/l

0.40

103

470

Autoimmune diseases excluding thyroid diseases, strict definition

381

1328

1.56

13.84

1.7

1.6

3.60

9.57

nmol/l

0.75

318

1092

Polycystic ovarian syndrome, broad definition

274

2.69

13.76

1.3

1.4

0.83

1.87

nmol/l

1.55

208

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

416

1759

1.52

13.76

1.7

1.6

15.28

5.25

nmol/l

0.37

347

1455

Angina pectoris

192

686

1.86

13.72

1.6

29.15

8.64

nmol/l

0.35

163

574

Other arrhythmias

262

1169

1.68

13.47

1.5

1.6

2.03

5.49

nmol/l

1.00

211

965

Myalgia

116

542

2.15

13.42

1.4

1.7

3.46

9.32

nmol/l

0.65

444

Convulsions, not elsewhere classified

428

2.29

13.38

1.3

1.6

4.02

9.16

nmol/l

0.41

345

Pain in thoracic spine

308

2.55

13.28

1.5

1.7

4.34

12.87

nmol/l

0.50

248

Chronic rhinitis, nasopharyngitis and pharyngitis

150

773

1.95

13.27

1.7

1.6

2.48

14.09

nmol/l

0.94

112

652

Persons encountering health services in other circumstances

182

989

1.83

13.21

1.6

1.69

6.18

nmol/l

1.15

153

820

Rotator cuff syndrome

234

935

1.73

13.20

1.5

1.7

5.17

12.27

nmol/l

0.57

202

781

Other reaction to severe stress, and adjustment disorders

173

937

1.85

13.13

1.5

1.7

3.15

6.47

nmol/l

0.62

138

771

Acute upper respiratory infections

421

1683

1.50

13.04

1.6

1.89

8.51

nmol/l

1.29

327

1417

Cervicobrachial syndrome

440

2.26

12.97

1.5

1.6

7.54

10.37

nmol/l

0.18

369

Nonalcoholic fatty liver disease

227

2.80

12.88

1.5

1.7

2.34

6.14

nmol/l

0.99

180

Acute renal failure

374

2.36

12.79

1.6

3.52

6.81

nmol/l

1.13

316

Intestinal infectious diseases, including avohilmo, including avohilmo

460

1742

1.47

12.79

1.6

14.42

5.12

nmol/l

0.38

383

1441

Persons encountering health services in other circumstances, wide

448

1553

1.48

12.76

1.6

3.85

5.48

nmol/l

0.44

364

1298

Other and unspecified anaemias

154

762

1.90

12.62

1.6

1.7

3.77

8.37

nmol/l

0.78

131

636

Transport accidents

200

947

1.76

12.56

1.6

3.43

6.81

nmol/l

0.65

165

794

Other septicaemia

141

682

1.96

12.54

1.8

1.6

3.77

8.43

nmol/l

0.69

120

566

Other anaemias

155

769

1.89

12.48

1.6

1.7

5.20

8.33

nmol/l

0.42

132

643

All-cause Heart Failure

193

750

1.79

12.45

1.6

8.11

7.59

nmol/l

0.05

159

652

Aplastic and other anaemias

166

823

1.85

12.44

1.6

5.44

7.90

nmol/l

0.33

142

689

Deforming dorsopathies

121

592

2.05

12.42

2.0

1.6

3.95

8.50

nmol/l

0.51

491

Nontoxic multinodular goitre

355

2.38

12.39

1.7

1.6

4.59

4.89

nmol/l

0.05

297

ILD medications: prednisolone, methylprednisolone, prednisone

440

1661

1.47

12.33

1.7

1.6

16.20

4.91

nmol/l

0.44

351

1394

Rheumatism, unspecified

284

2.55

12.33

1.7

1.6

2.31

5.11

nmol/l

0.94

229

Injuries to the knee and lower leg

482

1801

1.45

12.27

1.6

1.7

3.03

8.11

nmol/l

0.93

391

1497

Heart failure, strict

196

768

1.78

12.27

1.6

1.7

8.03

7.62

nmol/l

0.04

161

669

Emotionally unstable personality disorder

315

2.46

12.22

1.7

1.6

71.37

2.88

nmol/l

0.50

244

Asthma-related pneumonia

142

737

1.93

12.22

1.7

1.6

2.71

7.72

nmol/l

0.86

117

610

Asthma, hospital admissions 3, pneumonia

142

738

1.92

12.17

1.7

1.6

2.71

7.71

nmol/l

0.86

117

611

Asthma-related pneumonia or sepsis

142

738

1.92

12.17

1.7

1.6

2.71

7.71

nmol/l

0.86

117

611

External causes of morbidity and mortality

264

797

1.66

12.17

1.7

1.6

5.90

6.62

nmol/l

0.07

211

660

Covid-19 confirmed case

151

803

1.88

12.16

1.7

5.60

7.59

nmol/l

0.23

131

658

Dermatitis

256

1547

1.62

12.13

1.6

4.90

5.01

nmol/l

0.02

218

1293

Acute tubulo-interstitial nephritis

246

1263

1.65

12.13

1.6

6.06

9.33

nmol/l

0.30

211

1053

Diseases of the digestive system

171

940

1.81

12.12

1.6

3.69

7.13

nmol/l

0.70

140

784

Erysipelas, including avohilmo

272

1251

1.61

12.09

1.6

4.67

5.60

nmol/l

0.18

219

1032

Post-traumatic stress disorder

213

2.79

12.04

1.6

1.7

1.87

3.34

nmol/l

0.64

163

Sub-endpoint used in defining T1D endpoints

126

623

2.00

12.01

1.5

1.7

3.94

9.11

nmol/l

0.62

103

500

Follow-up examination after treatment for conditions other than malignant neoplasms

155

543

1.91

11.98

1.6

1.5

2.47

5.15

nmol/l

1.59

134

450

Autoimmune diseases related-to ILD

346

1909

1.52

11.94

1.6

2.85

7.59

nmol/l

0.92

275

1595

Other bacterial diseases

365

1602

1.51

11.94

1.7

1.6

5.76

8.08

nmol/l

0.27

307

1324

Hypoparathyroidism

4.73

11.91

1.5

1.6

4.10

1.86

nmol/l

0.73

Disorders of synovium and tendon

219

1103

1.69

11.87

1.6

1.7

2.15

10.82

nmol/l

1.01

178

916

Other septicaemia, including avohilmo

142

699

1.91

11.85

1.8

1.6

3.77

8.27

nmol/l

0.68

120

578

Cholecystectomy

279

1497

1.59

11.81

1.7

1.6

3.60

8.91

nmol/l

0.76

232

1258

Diseases of the ear and mastoid process

469

1626

1.45

11.74

1.7

1.6

3.95

8.04

nmol/l

0.57

377

1358

Cough

147

731

1.88

11.68

1.6

4.45

7.76

nmol/l

0.45

121

619

Injuries to the abdomen, lower back, lumbar spine and pelvis

167

917

1.80

11.63

1.7

1.6

5.08

6.44

nmol/l

0.18

137

755

Benign neoplasm of colon, rectum, anus and anal canal

224

1138

1.67

11.60

1.5

1.7

3.33

6.59

nmol/l

0.85

185

961

Dysphagia

462

2.15

11.56

1.6

8.08

3.75

nmol/l

0.51

384

Supplementary factors related to causes of morbidity and mortality classified elsewhere

142

756

1.89

11.49

1.5

1.6

4.23

7.57

nmol/l

0.48

114

618

Volume depletion

123

3.35

11.47

1.3

1.6

2.96

7.32

nmol/l

0.66

104

COPD, early/later onset

153

694

1.85

11.44

1.6

5.64

8.52

nmol/l

0.34

127

591

Carpal tunnel syndrome

241

1285

1.63

11.44

1.5

1.7

4.44

5.85

nmol/l

0.25

200

1081

Early onset COPD

420

2.20

11.37

1.6

1.7

5.73

11.18

nmol/l

0.41

349

Other diseases of urinary system

378

1425

1.49

11.28

1.5

1.6

2.23

9.20

nmol/l

1.06

315

1184

COPD, hospital admissions

150

682

1.86

11.28

1.6

5.72

8.63

nmol/l

0.34

124

581

Thyrotoxicosis, other and/or unspecified

415

2.20

11.28

1.7

1.6

3.79

4.40

nmol/l

0.11

341

Allergic asthma (mode), excluding more controls

102

475

2.10

11.20

1.5

1.6

2.96

18.71

nmol/l

0.71

395

Spondylolisthesis/Spondylolysis

347

2.32

11.17

2.1

1.7

5.07

12.76

nmol/l

0.53

293

COPD related to multimorbidity

128

557

1.95

11.11

1.6

6.52

5.89

nmol/l

0.10

106

478

Coxibs

105

252

2.19

11.10

1.8

1.7

7.47

11.43

nmol/l

0.17

216

Other disorders of skin and subcutaneous tissue

280

1517

1.56

11.10

1.8

1.6

3.39

8.89

nmol/l

0.81

231

1264

Other disorders of lacrimal gland

158

880

1.80

11.08

1.6

3.41

6.30

nmol/l

0.48

129

731

Disturbance of activity and attention

352

2.29

11.05

1.5

1.7

1.21

1.63

nmol/l

1.45

270

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

138

451

1.93

11.03

1.6

1.5

4.44

2.76

nmol/l

0.49

112

358

Unspecified mental disorder

174

998

1.75

11.03

1.5

1.7

34.64

6.57

nmol/l

0.43

139

814

Persons encountering health services for other counselling and medical advice, not elsewhere classified

424

1552

1.45

11.02

1.6

16.90

5.48

nmol/l

0.43

345

1297

Bacterial pneumoniae

152

731

1.83

11.00

1.7

1.6

4.41

7.71

nmol/l

0.46

126

607

COPD-related respiratory insufficiency

174

2.89

10.93

1.7

1.8

2.44

8.99

nmol/l

1.24

149

Major coronary heart disease event excluding revascularizations

190

724

1.73

10.91

1.5

1.6

29.38

8.42

nmol/l

0.37

166

605

KRA_PSY_EATING, excluding more controls

178

2.86

10.89

1.5

1.8

1.56

2.11

nmol/l

0.45

138

Cholelithiasis

322

1450

1.52

10.88

1.7

1.6

3.61

8.96

nmol/l

0.74

270

1220

Allergic asthma (mode)

102

481

2.08

10.86

1.5

1.6

2.96

18.58

nmol/l

0.72

400

Other symptoms and signs involving the digestive system and abdomen

327

2.34

10.83

1.6

1.7

2.50

3.62

nmol/l

0.43

264

Benign neoplasm of other and ill-defined parts of digestive system

366

2.25

10.73

2.2

1.7

1.70

7.13

nmol/l

2.45

304

Mycoses, including avohilmo

374

1950

1.46

10.72

1.6

18.78

4.88

nmol/l

0.46

297

1624

Other diseases of upper respiratory tract

409

1471

1.45

10.50

1.7

1.6

3.58

8.97

nmol/l

0.77

319

1246

Cervicalgia

408

2.17

10.50

1.5

1.6

1.66

11.30

nmol/l

0.97

338

Bacterial pneumonia, not elsewhere classified

145

698

1.83

10.49

1.7

1.6

4.53

7.99

nmol/l

0.46

120

577

Disorders of eyelid, lacrimal system and orbit

338

1671

1.48

10.41

1.5

1.7

5.77

7.83

nmol/l

0.23

281

1391

Arthropathies

362

1235

1.48

10.35

1.6

5.33

9.90

nmol/l

0.45

295

1022

Hyperkinetic disorders

381

2.19

10.33

1.5

1.7

3.29

1.67

nmol/l

0.35

294

Sulfonylureas

359

2.11

10.16

1.7

1.6

6.76

5.35

nmol/l

0.20

315

Candidiasis, including avohilmo

140

773

1.82

10.16

1.5

1.7

46.21

4.28

nmol/l

0.50

104

640

Acute upper respiratory infections of multiple and unspecified sites

310

1507

1.50

10.15

1.6

1.7

2.87

9.01

nmol/l

0.95

243

1265

Benign neoplasm: Colon

186

1042

1.68

10.13

1.5

1.7

2.67

7.11

nmol/l

1.22

154

882

ILD medications

444

1692

1.42

10.11

1.6

16.45

4.96

nmol/l

0.46

357

1418

Intracranial injury

226

1321

1.60

10.10

1.6

26.72

5.82

nmol/l

0.42

183

1104

Codes for special purposes

214

1318

1.61

10.05

1.8

1.6

28.20

5.65

nmol/l

0.46

183

1092

Cholelithiasis, broad definition with cholecystitis

328

1470

1.49

10.05

1.7

1.6

3.59

8.86

nmol/l

0.74

274

1237

Exposure to unspecified factor

404

1929

1.43

10.00

1.7

1.6

3.12

7.84

nmol/l

0.91

335

1593

Type of accident

130

707

1.85

9.92

1.5

1.6

4.43

8.02

nmol/l

0.48

107

575

Bacterial pneumonia (organism specified)

159

828

1.74

9.88

1.7

1.6

4.45

7.74

nmol/l

0.52

131

685

Provisional assignment of new diseases of uncertain etiology

213

1317

1.61

9.86

1.8

1.6

28.34

5.65

nmol/l

0.46

182

1091

Subjective visual disturbances

114

596

1.92

9.83

1.6

4.17

5.23

nmol/l

0.21

488

Other general symptoms and signs

3.65

9.82

1.8

1.7

4.66

2.46

nmol/l

0.42

Thyrotoxicosis

112

584

1.93

9.74

1.7

3.46

4.32

nmol/l

0.22

479

Gonarthrosis

231

813

1.61

9.73

1.7

1.6

2.92

13.54

nmol/l

0.89

194

685

Polyuria

415

2.11

9.69

1.5

1.6

1.80

5.15

nmol/l

2.33

345

Continuous positive airway pressure

161

2.70

9.68

1.7

2.25

3.50

nmol/l

0.47

133

Diaphragmatic hernia

133

735

1.82

9.64

1.8

1.6

3.62

7.45

nmol/l

0.52

109

612

Chronic diseases of tonsils and adenoids

316

1342

1.49

9.62

1.7

1.6

2.58

9.44

nmol/l

0.96

247

1131

Migraine without aura and triptan purchases

451

2.05

9.55

1.6

1.7

3.62

3.26

nmol/l

0.07

369

Thyroiditis, ILD-related definition

271

2.38

9.52

1.7

1.82

3.91

nmol/l

1.36

210

Disorders of lacrimal system

179

1062

1.66

9.49

1.6

1.7

3.62

10.76

nmol/l

0.70

145

880

Cutaneous abscess, furuncle and carbuncle

118

632

1.87

9.47

1.7

3.89

8.96

nmol/l

0.62

102

505

Nontoxic goitre/thyroid nodule

117

625

1.88

9.47

1.7

1.6

4.14

4.20

nmol/l

0.01

515

Emphysema

3.46

9.46

1.2

2.0

12.04

13.62

nmol/l

0.06

Kela-code for severe mental illness

152

879

1.73

9.45

1.5

1.7

37.95

7.19

nmol/l

0.41

123

708

Substance use, excluding alcohol

446

2.05

9.45

1.5

1.6

2.00

10.05

nmol/l

0.80

351

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

388

1724

1.42

9.44

1.6

3.05

8.33

nmol/l

0.91

320

1423

Other external causes of accidental injury

308

1029

1.50

9.39

1.6

4.67

6.46

nmol/l

0.28

249

860

Bipolar affective disorders

407

2.10

9.39

1.7

61.91

9.18

nmol/l

0.43

332

Stroke, excluding SAH

192

843

1.65

9.35

1.6

4.33

7.52

nmol/l

0.54

160

713

Female infertility, associated with anovulation

185

2.67

9.27

1.9

1.6

0.96

2.07

nmol/l

1.08

154

Arthrosis

262

931

1.54

9.27

1.7

1.6

5.56

12.30

nmol/l

0.54

228

780

Fracture of lumbar spine and pelvis

435

2.05

9.24

1.9

1.6

5.78

5.81

nmol/l

0.01

360

Cystitis

320

1295

1.47

9.18

1.5

1.7

2.48

9.83

nmol/l

1.01

264

1081

Trochanteric bursitis

301

2.27

9.15

1.6

1.7

2.50

5.93

nmol/l

1.22

245

Disorders of ocular muscles, binocular movement, accommodation and refraction

206

1290

1.59

9.09

1.5

1.6

3.36

9.69

nmol/l

0.76

167

1058

Other female pelvic inflammatory diseases

367

2.14

9.04

1.6

1.7

3.42

3.39

nmol/l

0.00

293

Migraine with aura

110

585

1.89

9.03

1.3

1.7

1.49

3.67

nmol/l

1.65

480

Ischaemic Stroke, excluding all haemorrhages

178

790

1.66

9.02

1.6

4.56

7.85

nmol/l

0.52

146

672

Dental pulpitis, including avohilmo

378

1712

1.42

8.97

1.6

1.7

17.19

5.23

nmol/l

0.39

300

1423

Abnormal serum enzyme levels

491

1.95

8.95

1.5

1.7

8.00

10.60

nmol/l

0.17

415

Gonarthrosis [arthrosis of knee](FG)

258

971

1.53

8.90

1.8

1.6

2.79

12.17

nmol/l

0.95

217

817

Emotional disorders starting during childhood or adolecense, excluding more controls

3.49

8.89

1.7

1.5

1.31

1.57

nmol/l

0.25

Inflammatory diseases of female pelvic organs

285

1313

1.49

8.88

1.6

1.7

22.39

2.92

nmol/l

0.49

220

1086

Other sleep disorders

195

2.58

8.87

1.6

2.36

8.31

nmol/l

1.10

153

Non-rheumatic valve diseases

152

629

1.73

8.85

1.5

1.7

3.98

8.35

nmol/l

0.53

133

517

Valvular heart disease excluding rheumatic fever

153

635

1.72

8.84

1.5

1.7

3.96

8.30

nmol/l

0.53

134

522

Soft tissue disorders related to use, overuse and pressure

107

569

1.89

8.81

1.5

1.7

2.24

8.76

nmol/l

0.90

473

Neuralgia and neuritis, unspecified

3.26

8.62

1.2

1.7

1.52

5.19

nmol/l

1.25

432

1584

1.38

8.61

1.7

1.6

2.19

8.77

nmol/l

1.17

337

1340

Non-ischemic cardiomyopathy

102

422

1.92

8.55

1.9

1.6

9.30

10.55

nmol/l

0.07

365

Mental and behavioural disorders due to psychoactive substance use

216

1280

1.55

8.51

1.5

1.6

27.41

6.35

nmol/l

0.41

178

1063

Substance abuse

210

1257

1.55

8.45

1.6

28.17

6.25

nmol/l

0.41

173

1044

Myocardial infarction

146

593

1.72

8.42

1.5

1.6

3.50

9.55

nmol/l

0.84

125

498

Transient ischemic attack

167

807

1.65

8.42

1.6

4.27

7.77

nmol/l

0.58

148

683

Disorders of conjunctiva

339

1854

1.42

8.42

1.7

1.6

3.91

7.80

nmol/l

0.64

279

1531

Fracture of lower leg, including ankle

211

1341

1.55

8.39

1.5

1.6

4.23

9.77

nmol/l

0.67

173

1110

COPD, hospital admissions 3, with asthma pneumonia sepsis

367

2.01

8.35

1.7

4.86

6.62

nmol/l

0.39

314

Other and unspecified dermatitis

204

1314

1.56

8.33

1.6

5.11

5.46

nmol/l

0.05

173

1100

Pain and other conditions associated with female genital organs and menstrual cycle

101

445

1.90

8.31

1.6

1.7

3.32

3.45

nmol/l

0.03

379

Injury, poisoning and certain other consequences of external causes

206

649

1.59

8.24

1.7

6.58

7.04

nmol/l

0.04

164

535

Abnormal findings on diagnostic imaging of central nervous system

3.23

8.22

2.2

1.7

5.27

5.42

nmol/l

0.01

Unspecified/other endometriosis

205

2.45

8.15

1.3

1.7

1.77

4.09

nmol/l

1.09

173

Flat foot [pes planus] (acquired)

186

2.54

8.13

1.8

1.7

1.82

5.24

nmol/l

0.80

148

Accidents

300

1029

1.46

8.12

1.6

4.68

6.46

nmol/l

0.28

243

860

Polyarthropathies

247

1055

1.51

8.11

1.6

1.7

3.60

11.03

nmol/l

0.75

199

883

Factors influencing health status and contact with health services

228

2.03

8.09

1.8

1.4

3.67

5.44

nmol/l

0.26

192

Other medical care

163

836

1.64

8.08

1.7

1.6

6.06

6.97

nmol/l

0.10

137

694

Pulmonary heart disease, diseases of pulmonary circulation

111

615

1.81

8.06

2.0

1.6

4.28

9.16

nmol/l

0.63

509

Other diseases of anus and rectum

105

571

1.84

8.00

1.5

1.7

3.53

9.15

nmol/l

0.70

470

Cerebral cysts

120

2.94

7.97

1.3

1.8

3.61

3.28

nmol/l

0.05

Leisure time condition

414

1.99

7.92

1.4

1.6

4.08

6.23

nmol/l

0.51

326

Heart failure and coronary heart disease

126

502

1.76

7.87

1.6

7.20

10.75

nmol/l

0.30

434

Erysipelas

185

1015

1.57

7.81

1.6

5.35

6.63

nmol/l

0.20

149

839

Diplopia

259

2.25

7.71

1.6

5.02

8.98

nmol/l

0.51

208

Other and unspecified nonorganic psychotic disorders

467

1.91

7.70

1.6

59.29

9.92

nmol/l

0.40

363

COPD, hospital admission 2, with asthma infections

100

465

1.86

7.70

1.6

4.31

6.50

nmol/l

0.65

395

Oxicams

216

2.08

7.69

1.6

1.7

5.81

12.97

nmol/l

0.30

188

Other postsurgical states

128

2.83

7.68

1.4

1.9

2.87

9.91

nmol/l

1.01

107

Stroke, including SAH

198

916

1.55

7.68

1.6

5.50

6.84

nmol/l

0.18

164

771

Other arthrosis

186

790

1.58

7.67

1.6

4.45

13.71

nmol/l

0.67

160

669

Ovarian cyst

146

494

1.70

7.65

1.4

1.7

2.20

3.41

nmol/l

1.07

123

426

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

132

782

1.69

7.63

1.6

45.67

6.53

nmol/l

0.43

643

Chronic laryngitis and laryngotracheitis

273

2.21

7.63

1.7

1.8

4.24

7.59

nmol/l

0.61

231

Endometriosis

142

486

1.70

7.60

1.4

1.7

1.51

3.45

nmol/l

2.74

113

419

Heart failure and bmi 25plus

119

448

1.78

7.58

1.9

1.8

10.34

10.60

nmol/l

0.01

388

Haemorrhoids and perianal venous thrombosis

114

646

1.76

7.52

1.5

1.7

6.47

8.43

nmol/l

0.15

537

Asthma and allergy, excluding more controls

252

2.24

7.51

1.4

1.6

3.59

2.51

nmol/l

0.37

204

Insulin, fast-acting (human)

301

2.14

7.50

1.4

1.6

1.59

5.84

nmol/l

1.59

235

Dentofacial anomalies [including malocclusion]

299

1652

1.42

7.50

1.7

1.6

21.38

5.15

nmol/l

0.42

236

1363

Viral and other specified intestinal infections, including avohilmo

125

705

1.71

7.47

1.5

1.6

3.60

7.69

nmol/l

0.55

559

Generalized anxiety disorder

425

1.94

7.35

1.7

1.61

3.97

nmol/l

1.20

339

Asthma and allergy

255

2.22

7.31

1.4

1.6

3.59

2.46

nmol/l

0.39

207

Polyarthrosis

363

1.97

7.30

1.5

1.7

5.02

4.35

nmol/l

0.09

308

Cerebral palsy and other paralytic syndromes

228

2.29

7.24

1.4

1.7

3.72

6.64

nmol/l

0.43

182

Urinary track infection

256

873

1.47

7.21

1.5

1.7

2.86

8.79

nmol/l

0.47

213

710

Extrapyramidal and movement disorders

135

819

1.65

7.16

1.9

1.6

5.65

7.41

nmol/l

0.21

110

679

Other disorders of eyelid

149

873

1.61

7.12

1.6

8.40

4.35

nmol/l

0.71

128

732

Excessive, frequent and irregular menstruation

158

518

1.63

7.12

1.6

1.7

1.58

3.70

nmol/l

2.70

123

445

Phobic anxiety disorders

334

2.04

7.09

1.5

1.7

1.26

3.25

nmol/l

1.71

262

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

3.39

7.07

1.6

12.27

2.88

nmol/l

0.53

Other enthesopathies

111

641

1.74

7.06

1.5

1.7

1.97

8.28

nmol/l

0.99

525

Vasomotor and allergic rhinitis

154

946

1.59

7.05

2.0

1.6

2.14

12.25

nmol/l

1.01

121

788

Gastroduodenal ulcer

431

1.90

7.02

1.8

1.6

9.74

5.87

nmol/l

0.50

367

Injuries to the head

422

1877

1.33

7.02

1.6

16.61

4.91

nmol/l

0.44

339

1564

Heartburn

225

2.28

7.01

1.7

4.28

4.59

nmol/l

0.04

175

Artrosis, including avohilmo

298

1154

1.42

6.99

1.6

7.22

10.12

nmol/l

0.23

257

959

Noninflammatory disorders of female genital tract

166

519

1.61

6.97

1.7

2.31

3.70

nmol/l

1.12

120

446

Speech and linguistic disorders, excluding more controls

137

2.62

6.93

1.9

1.5

1.61

3.39

nmol/l

0.54

101

Diseases of pulp and periapical tissues, including avohilmo

379

1444

1.36

6.90

1.6

1.7

5.22

4.96

nmol/l

0.04

303

1202

Schizophrenia, schizotypal and delusional disorders

125

751

1.67

6.90

1.6

43.91

7.84

nmol/l

0.41

104

606

Inflammatory disease of uterus

353

1.99

6.86

1.3

1.7

1.23

3.08

nmol/l

1.80

278

Mental and behavioural disorders due to tobacco

184

2.41

6.84

1.6

1.7

1.97

7.36

nmol/l

1.17

148

Smoking dependency

184

2.41

6.84

1.6

1.7

1.97

7.31

nmol/l

1.17

149

Disorders of refraction and accommodation

124

743

1.67

6.81

1.6

1.7

2.17

7.54

nmol/l

0.94

103

602

Schizophrenia or delusion

124

747

1.66

6.78

1.6

44.28

7.87

nmol/l

0.41

103

603

Fall on same level involving ice and snow

219

1500

1.46

6.75

1.5

1.6

2.68

8.92

nmol/l

0.97

182

1246

Benign neoplasm of brain and other parts of central nervous system

121

2.75

6.70

1.9

1.8

2.67

5.21

nmol/l

0.68

101

Abnormal results of function studies

180

2.40

6.68

1.7

1.70

7.12

nmol/l

1.26

145

Myocardial infarction, strict

129

550

1.66

6.66

1.5

1.6

3.51

10.03

nmol/l

0.86

111

468

Conjunctivitis (acute, non atopic), including avohilmo

377

1694

1.34

6.64

1.7

1.6

3.01

8.36

nmol/l

0.91

305

1413

COPD, hospital admissions 1, only main diagnosis

103

508

1.75

6.57

1.5

1.6

5.12

6.52

nmol/l

0.23

435

Special screening examination for other diseases and disorders

201

2.30

6.48

2.1

1.4

2.79

5.72

nmol/l

0.65

166

Injuries to the thorax

154

989

1.56

6.47

1.7

1.6

2.77

6.96

nmol/l

1.00

132

816

Other retinal disorders

208

1074

1.47

6.44

1.5

1.7

16.46

4.30

nmol/l

0.57

181

895

Deviated nasal septum

110

651

1.69

6.42

1.8

1.6

6.54

8.14

nmol/l

0.15

562

Migraine, single triptan purchase ok & required. ICD-code if available is included

311

1535

1.37

6.42

1.6

1.86

5.51

nmol/l

1.57

247

1270

Triptan medication for migraine, single purchase ok

311

1535

1.37

6.42

1.6

1.86

5.51

nmol/l

1.57

247

1270

Eating disorder

234

2.19

6.40

1.5

1.7

1.56

2.48

nmol/l

0.46

181

Endometriosis of pelvic peritoneum

334

1.94

6.38

1.4

1.8

1.61

3.52

nmol/l

1.55

284

Chronic sinusitis

157

1016

1.55

6.37

1.6

4.31

11.48

nmol/l

0.65

129

856

Radiculopathy

268

2.10

6.34

1.8

1.6

3.52

7.57

nmol/l

0.88

219

Carbimazole or st.post thyroidectomy, condition for graves disease

499

1.79

6.33

1.8

1.7

5.62

4.22

nmol/l

0.25

398

Extreme obesity with alveolar hypoventilation

3.19

6.30

1.8

2.03

4.47

nmol/l

0.45

Abnormal involuntary movements

284

2.05

6.20

1.7

1.6

1.85

6.01

nmol/l

1.53

228

Obsessive-compulsive disorder

156

2.45

6.18

1.6

1.7

1.72

3.19

nmol/l

0.54

127

Other eating disorders

115

2.72

6.17

1.3

1.9

1.64

3.64

nmol/l

0.53

Emotional disorders and disorders of social functioning with onset specific to childhood

118

2.68

6.17

1.7

1.8

1.39

1.50

nmol/l

0.11

Atypical facial pain

104

2.81

6.16

1.4

1.8

1.43

3.93

nmol/l

1.15

Poisoning by drugs, medicaments and biological substances

100

585

1.72

6.15

1.5

1.7

59.37

7.80

nmol/l

0.44

469

Complications of internal orthopaedic prosthetic devices, implants and grafts

424

1.85

6.15

1.8

1.6

2.85

6.18

nmol/l

1.27

358

Conjunctivitis

303

1794

1.36

6.09

1.7

1.6

3.81

7.84

nmol/l

0.64

250

1475

Fracture of rib(s), sternum and thoracic spine

106

632

1.68

6.08

1.8

1.6

2.74

9.76

nmol/l

1.10

516

Any event in cancer register

335

1450

1.35

6.08

1.5

1.7

7.42

8.12

nmol/l

0.06

290

1181

Other complications of surgical and medical care, not elsewhere classified

201

2.25

6.07

1.7

3.33

7.06

nmol/l

0.72

160

Unspecified haematuria

129

654

1.61

6.04

1.5

1.6

10.20

7.96

nmol/l

0.17

110

548

Chronic gastritis

477

1.79

6.04

1.7

1.6

2.54

4.81

nmol/l

1.05

401

Procreative management

150

798

1.55

6.03

1.7

1.6

3.27

7.18

nmol/l

0.65

120

645

Implicit fungal Sepsis, including avohilmo

123

2.62

5.96

1.7

1.8

5.96

11.01

nmol/l

0.52

102

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

184

2.30

5.93

1.4

1.8

2.31

6.27

nmol/l

0.82

145

Hypotension

276

2.04

5.89

1.7

8.80

8.36

nmol/l

0.03

233

Bronchitis

403

1852

1.31

5.86

1.6

2.85

7.89

nmol/l

0.96

317

1548

Diseases of oral cavity, salivary glands and jaws

182

624

1.50

5.85

1.7

1.6

7.84

8.18

nmol/l

0.03

146

525

Hernia

330

1638

1.34

5.84

1.7

1.6

20.88

5.00

nmol/l

0.49

273

1362

Paralytic ileus and intestinal obstruction

431

1.81

5.83

1.5

1.7

3.16

10.48

nmol/l

0.71

358

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

403

1.84

5.83

1.5

1.6

80.77

3.13

nmol/l

0.48

318

Triptan medication for migraine, min. 3 purchases

245

1309

1.40

5.82

1.7

24.30

5.10

nmol/l

0.41

196

1074

Other diseases of intestine

271

2.04

5.80

1.6

1.7

2.79

6.39

nmol/l

1.16

223

Other and unspecified polyneuropathies, also in other diseases

347

1.91

5.79

1.4

1.7

3.50

7.64

nmol/l

1.27

297

Acute laryngitis and tracheitis

267

2.04

5.77

1.3

1.6

1.94

3.45

nmol/l

0.83

213

Misadventures to patients during surgical and medical care

292

1.99

5.77

1.7

1.6

7.70

6.90

nmol/l

0.07

229

Other specified and unspecified personality disorders

193

2.24

5.75

1.3

1.6

124.54

3.78

nmol/l

0.49

148

Fentanyl

125

2.56

5.75

1.4

1.6

6.04

12.43

nmol/l

0.58

101

Thiazolidinediones

174

2.31

5.75

1.5

1.7

3.84

7.27

nmol/l

0.58

151

Trigeminal neuralgia

114

2.65

5.73

1.6

1.8

1.36

3.80

nmol/l

1.34

Suicide or other Intentional self-harm

590

1.68

5.72

1.6

1.7

58.12

8.01

nmol/l

0.42

474

Chronic periodontitis, including avohilmo

355

1714

1.32

5.72

1.8

1.6

6.93

7.63

nmol/l

0.07

309

1412

Other CVD

342

1.91

5.69

1.6

8.12

7.72

nmol/l

0.03

288

Gingivitis and periodontal diseases

344

1332

1.33

5.68

1.7

1.6

6.34

5.27

nmol/l

0.17

290

1095

Malignant neoplasm, including Hilmo

309

1333

1.35

5.67

1.5

1.7

6.22

8.67

nmol/l

0.22

271

1086

Other systemic involvement of connective tissue (FG)

514

1.72

5.66

1.6

1.7

5.57

4.99

nmol/l

0.08

423

Alcohol use disorder, Swedish definition

177

1096

1.47

5.63

1.5

1.7

33.86

6.64

nmol/l

0.43

143

907

Disorder of the sleep-wake schedule

5.09

5.59

1.1

1.4

1.26

7.23

nmol/l

—

Malignant neoplasm, wide definition

309

1336

1.35

5.57

1.5

1.7

6.24

8.66

nmol/l

0.22

270

1089

Enlarged lymph nodes

269

2.01

5.54

1.7

1.65

13.29

nmol/l

0.72

224

Hernia of abdominal wall

149

987

1.51

5.54

1.6

1.7

42.84

6.39

nmol/l

0.50

120

828

Undetermined asthma, excluding more controls

222

2.12

5.54

1.6

1.7

2.91

3.33

nmol/l

0.13

179

Blepharochalasis

101

611

1.66

5.53

1.6

8.40

4.55

nmol/l

0.44

511

Other abnormal findings of blood chemistry

2.86

5.52

1.8

1.9

3.45

4.18

nmol/l

0.12

Other extrapyramidal and movement disorders in other diseases

551

1.69

5.51

1.7

1.6

5.34

5.33

nmol/l

0.00

450

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

335

1980

1.32

5.46

1.7

1.6

2.91

7.72

nmol/l

0.97

267

1647

Gastric ulcer

305

1.94

5.46

1.5

1.6

8.89

6.05

nmol/l

0.28

263

Chronic periodontitis, complicated

186

1258

1.44

5.45

1.8

1.6

9.36

5.00

nmol/l

0.63

165

1045

Other symptoms and signs involving the urinary system

185

2.23

5.43

1.8

1.9

5.81

7.52

nmol/l

0.15

155

Disorders of lens

211

918

1.43

5.43

1.6

1.7

6.00

6.56

nmol/l

0.06

182

762

Myocardial infarction, without ST-elevation

109

607

1.62

5.43

1.5

1.6

3.74

9.80

nmol/l

0.89

528

Other shoulder lesions

205

2.16

5.40

1.4

1.7

6.65

7.15

nmol/l

0.03

158

Acute sinusitis

203

1302

1.42

5.39

1.5

1.7

2.11

9.86

nmol/l

1.09

161

1085

Hypermobility syndrome

136

2.45

5.38

1.5

1.7

1.55

5.71

nmol/l

1.24

Cardiodefibrillation

100

607

1.65

5.35

1.5

1.6

3.84

9.75

nmol/l

0.84

523

Disorders of vestibular function (Vertigo)

159

1048

1.48

5.32

1.5

1.6

7.47

6.06

nmol/l

0.14

131

875

Eating disorders

280

1.97

5.31

1.5

1.7

1.54

2.89

nmol/l

0.81

221

Senile cataract

191

803

1.45

5.30

1.6

1.7

6.50

7.14

nmol/l

0.06

166

672

Later onset COPD, excluding more controls

242

1.93

5.28

1.5

1.6

5.51

4.06

nmol/l

0.28

208

Psychotic depression

2.72

5.26

2.0

1.6

2.97

2.28

nmol/l

0.24

Necrosis of pulp, including avohilmo

225

1609

1.38

5.22

1.4

1.6

3.91

8.49

nmol/l

0.59

187

1323

Tonsillectomy and adenotomy

233

1171

1.39

5.21

1.7

1.88

10.34

nmol/l

1.05

179

964

Periodontitis

352

1720

1.31

5.21

1.8

1.6

6.97

7.60

nmol/l

0.06

307

1418

Poisoning by medicine

530

1.68

5.20

1.6

1.7

65.72

8.39

nmol/l

0.43

422

Alcohol abuse, main dg, excluding more controls

262

1.99

5.20

1.7

1.6

5.03

14.92

nmol/l

0.49

206

Persistent mood disorders

382

1.81

5.20

1.7

1.6

1.34

10.27

nmol/l

0.80

314

Papulosquamous disorders

139

921

1.51

5.19

1.6

1.7

3.56

6.79

nmol/l

0.59

114

764

Emotional disorders starting during childhood or adolescence

119

2.52

5.18

1.7

1.31

1.44

nmol/l

0.14

Diseases of salivary glands

124

802

1.55

5.18

1.3

1.7

1.91

7.47

nmol/l

1.13

103

656

Presence of cardiac and vascular implants and grafts

126

595

1.56

5.17

1.7

2.19

10.40

nmol/l

1.39

103

513

Diseases of inner ear

181

1208

1.44

5.17

1.5

1.7

7.81

5.70

nmol/l

0.27

149

1012

Diseases of male genital organs

134

432

1.56

5.16

1.4

1.6

28.34

3.92

nmol/l

0.76

113

365

Pulmonary embolism

577

1.65

5.15

2.0

1.6

4.44

9.66

nmol/l

0.63

478

Endometriosis of ovary

360

1.81

5.14

1.6

1.7

1.94

3.91

nmol/l

1.63

313

Other arthritis (FG)

108

678

1.60

5.13

1.5

1.7

2.65

7.69

nmol/l

0.77

559

Injuries to the ankle and foot

281

1798

1.34

5.13

1.5

1.7

2.23

8.21

nmol/l

1.17

226

1480

Temporomandibular joint disorders, including avohilmo

190

1298

1.42

5.13

1.7

1.6

30.70

5.23

nmol/l

0.43

153

1064

Metatarsalgia

203

2.13

5.12

1.7

2.84

6.03

nmol/l

0.69

159

Bacterial infection, other or unspecified, including avohilmo

183

1046

1.43

5.11

1.7

1.6

7.97

6.32

nmol/l

0.22

154

869

Pregnancy hypertension

176

1093

1.44

5.10

1.9

1.6

3.72

7.41

nmol/l

0.33

138

892

Glaucoma

170

995

1.45

5.10

1.5

1.6

2.68

7.20

nmol/l

1.15

138

842

malignant neoplasm of male genital organs

221

1.86

5.04

1.4

1.9

10.73

13.08

nmol/l

0.08

194

Acne, including avohilmo

104

522

1.62

5.03

2.0

1.7

1.56

2.67

nmol/l

1.00

409

Pulmonary heart disease

581

1.64

5.02

2.0

1.6

4.44

9.62

nmol/l

0.63

481

198

1225

1.41

5.02

1.6

30.44

6.39

nmol/l

0.43

161

1018

Unspecified fall

175

1199

1.43

5.01

1.4

1.7

5.42

5.60

nmol/l

0.02

144

992

Other noninflammatory disorders of uterus, except cervix

301

1.76

5.01

1.5

1.7

1.79

4.56

nmol/l

2.39

267

Other disorders of bone

431

1.75

5.00

1.5

1.7

3.41

9.57

nmol/l

0.51

340

Caries of dentine, including avohilmo

259

971

1.36

5.00

1.7

1.6

6.78

5.93

nmol/l

0.09

209

808

Other and unspecified drugs and medicaments

192

2.15

5.00

1.4

1.8

2.37

6.50

nmol/l

0.92

152

Migraine with aura and triptan purchases

424

1.75

4.99

1.3

1.6

1.31

2.76

nmol/l

1.42

345

Undetermined asthma

232

2.03

4.97

1.6

1.7

2.91

3.58

nmol/l

0.23

188

Acne

272

1.95

4.97

1.8

1.6

1.60

2.48

nmol/l

0.51

203

Symptoms and signs involving speech and voice

117

755

1.55

4.96

1.7

1.6

3.19

7.88

nmol/l

0.72

625

Solid cancers, including Hilmo

298

1308

1.33

4.95

1.5

1.7

7.58

8.79

nmol/l

0.09

263

1067

Glaucoma suspect

117

755

1.55

4.94

1.4

1.6

2.26

5.01

nmol/l

1.99

632

Malignant neoplasm of prostate

206

1.87

4.92

1.3

1.9

11.15

13.79

nmol/l

0.08

182

Sequelae of injuries, of poisoning and of other consequences of external causes

539

1.66

4.91

1.6

1.61

9.97

nmol/l

1.11

432

Non-allergic asthma (mode), excluding more controls

328

1.85

4.91

1.5

1.7

4.22

10.13

nmol/l

0.34

266

Sequelae of external causes of morbidity and mortality

563

1.64

4.87

1.6

3.75

5.66

nmol/l

0.70

458

Other follicular disorders

168

2.22

4.87

1.9

1.6

1.23

3.84

nmol/l

1.08

127

Other disorders of kidney and ureter

255

1.97

4.86

1.8

1.7

13.35

6.32

nmol/l

0.36

214

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

120

773

1.54

4.86

1.8

1.6

2.31

10.43

nmol/l

0.62

630

Peripheral arterial reconstruction

255

1.97

4.85

1.7

11.90

6.98

nmol/l

0.26

221

Stomatitis and related lesions

474

1.69

4.80

1.6

1.7

3.71

4.82

nmol/l

0.27

381

Dental operations

190

685

1.43

4.79

1.6

1.7

9.02

7.54

nmol/l

0.13

152

578

Polyneuropathies and other disorders of the peripheral nervous system

422

1.74

4.79

1.4

1.7

3.34

6.79

nmol/l

1.21

349

Viral and other specified intestinal infections

507

1.66

4.78

1.4

1.6

4.64

5.13

nmol/l

0.08

393

GI-bleeding

606

1.60

4.73

1.7

1.6

4.08

9.58

nmol/l

0.73

504

Thyrotoxicosis with diffuse goitre

300

1.87

4.72

1.8

1.6

4.85

4.56

nmol/l

0.03

239

Disorders of psychological development

277

1.88

4.72

1.8

1.6

1.50

3.25

nmol/l

0.93

210

Cerebral aneurysm, nonruptured

177

2.16

4.71

2.1

1.7

3.96

8.36

nmol/l

0.69

149

Hyperplasia of prostate

274

1.71

4.66

1.7

1.6

15.30

3.48

nmol/l

0.96

240

Diabetes mellitus in pregnancy

150

648

1.47

4.66

1.7

36.53

2.53

nmol/l

0.48

124

518

Atopic dermatitis

236

1392

1.35

4.66

1.8

1.6

26.35

5.52

nmol/l

0.44

190

1135

Allergic rhinitis

125

820

1.51

4.65

2.0

1.7

2.29

13.22

nmol/l

0.90

672

Pacemaker

579

1.59

4.64

1.6

6.26

6.14

nmol/l

0.01

495

Sequelae with surgical and medical care as external cause

434

1.71

4.62

1.7

3.22

6.58

nmol/l

1.34

353

Chronic apical periodontitis

399

1768

1.27

4.62

1.6

4.55

7.79

nmol/l

0.45

331

1464

Conduction disorders

417

1.66

4.61

1.7

4.48

5.62

nmol/l

0.18

345

Adverse effects, not elsewhere classified

495

1.66

4.61

1.5

1.7

4.09

4.48

nmol/l

0.07

397

Other diseases of the digestive system

613

1.59

4.53

1.7

1.6

4.08

9.44

nmol/l

0.72

509

Venous thromboembolism

163

1104

1.42

4.52

1.9

1.6

3.85

6.55

nmol/l

0.61

139

920

Gout

379

1.70

4.51

1.4

1.6

6.46

11.37

nmol/l

0.32

327

Use of pramipexole

460

1.68

4.51

1.8

1.6

4.57

6.18

nmol/l

0.35

377

Solid cancers

285

1271

1.32

4.48

1.6

1.7

7.89

8.86

nmol/l

0.07

252

1039

Vasculitis limited to skin, not elsewhere classified

3.30

4.48

2.1

1.9

13.74

5.15

nmol/l

0.32

Benign neoplasm: Liver/bile ducts

3.30

4.48

1.9

2.0

1.84

5.99

nmol/l

—

Malignant neoplasm

291

1301

1.31

4.46

1.6

1.7

7.78

8.83

nmol/l

0.08

257

1062

Viral meningitis, including avohilmo

2.71

4.42

1.4

1.7

1.25

4.43

nmol/l

0.73

Coxarthrosis [arthrosis of hip](FG)

160

768

1.43

4.42

1.5

1.6

4.93

7.88

nmol/l

0.43

132

647

Malignant neoplasm

291

1303

1.31

4.42

1.6

1.7

7.79

8.82

nmol/l

0.08

256

1063

Non-allergic asthma (mode)

340

1.78

4.41

1.5

1.7

4.22

10.02

nmol/l

0.35

277

Bacterial infection, other or unspecified

161

955

1.42

4.40

1.8

1.6

7.92

6.72

nmol/l

0.14

138

793

Single delivery by forceps and vacuum extractor

378

0.46

4.40

1.7

1.6

1.08

2.59

nmol/l

1.37

299

Ventral hernia

479

1.65

4.38

1.6

8.67

9.57

nmol/l

0.05

389

Mycoses

103

666

1.55

4.38

1.6

1.7

5.98

8.47

nmol/l

0.26

549

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

187

1173

1.38

4.37

1.9

1.6

3.57

7.04

nmol/l

0.34

147

965

Viral meningitis

2.75

4.36

1.4

1.7

1.23

4.66

nmol/l

0.74

Benign neoplasm: Liver

3.37

4.33

1.9

2.0

1.84

6.29

nmol/l

—

Coxarthrosis

150

669

1.45

4.32

1.6

4.84

7.64

nmol/l

0.34

123

564

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

150

653

1.45

4.31

1.7

1.79

10.58

nmol/l

0.54

116

523

Other diseases of lip and oral mucosa

149

1043

1.43

4.30

1.7

1.6

3.19

6.39

nmol/l

0.71

124

856

183

1182

1.38

4.29

1.5

1.7

32.79

6.25

nmol/l

0.44

149

984

Sequelae of cerebrovascular disease

101

556

1.55

4.26

1.7

1.6

3.44

9.60

nmol/l

0.80

472

Other degenerative diseases of the nervous system

342

1.67

4.24

1.5

1.6

5.37

11.82

nmol/l

0.42

290

Mixed and other personality disorders

172

2.10

4.22

1.5

1.6

2.47

4.16

nmol/l

0.55

134

Inflammatory diseases of prostate (prostatitis)

172

2.10

4.21

1.4

1.7

66.86

3.92

nmol/l

0.46

149

Other cataract

132

668

1.47

4.21

1.4

1.7

2.58

8.02

nmol/l

0.87

110

556

Intestinal stricture

609

1.56

4.21

1.5

1.7

4.46

9.32

nmol/l

0.61

505

malignant neoplasm of male genital organs, including Hilmo

230

1.75

4.20

1.4

1.8

10.98

12.68

nmol/l

0.05

201

Hypertrophy of breast in women and men

485

1.63

4.20

1.5

1.7

4.05

2.92

nmol/l

0.26

389

Hypoglycaemia, other or unspecified

127

2.30

4.19

1.9

1.7

8.37

6.82

nmol/l

0.10

107

Focal epilepsy

462

1.65

4.18

1.4

1.6

2.76

6.25

nmol/l

1.40

362

Other diseases of pancreas

153

2.17

4.17

1.8

1.7

2.80

7.60

nmol/l

0.89

132

Disorders of choroid and retina

252

1340

1.32

4.16

1.4

1.7

14.01

3.96

nmol/l

0.57

218

1118

Disorders of sclera, cornea, iris and ciliary body

191

1404

1.36

4.15

1.6

3.46

9.34

nmol/l

0.79

153

1172

Menorrhagia

122

453

1.50

4.13

1.5

1.7

1.56

3.58

nmol/l

2.66

391

Psoriasis

100

652

1.54

4.12

1.6

3.33

8.45

nmol/l

0.70

533

Other obstetric conditions, not elsewhere classified

151

666

1.43

4.11

1.7

1.77

10.37

nmol/l

0.54

117

535

Lesion of ulnar nerve

264

1.86

4.11

1.7

11.77

17.20

nmol/l

0.20

209

Cyst of kidney

122

2.31

4.10

1.9

1.8

8.34

4.96

nmol/l

0.19

109

Monoamine oxidase A inhibitors

208

1.98

4.10

1.2

1.7

2.14

5.44

nmol/l

1.21

171

Retention of urine

492

1.56

4.10

1.7

8.63

9.96

nmol/l

0.07

409

DVT of lower extremities and pulmonary embolism

125

852

1.46

4.07

2.0

1.6

4.32

7.57

nmol/l

0.55

108

709

Internal derangement of knee

123

831

1.47

4.07

1.3

1.6

2.68

13.12

nmol/l

0.87

102

690

Propionic acid derivatives

265

1.64

4.06

1.6

1.7

3.71

11.05

nmol/l

0.38

224

Pruritus

251

1.88

4.05

1.7

3.36

6.22

nmol/l

0.59

198

Other enthesopathy of foot (+metatarsalgia)

223

1.94

4.05

1.7

1.8

2.84

5.57

nmol/l

0.64

178

Other disorders of patella

376

1.71

4.03

1.6

5.29

10.19

nmol/l

0.31

303

Mental and behavioural disorders due to alcohol

159

1086

1.40

3.99

1.6

37.09

6.63

nmol/l

0.43

129

899

Other and unspecified effects of external causes

107

714

1.50

3.98

1.5

1.7

5.47

4.35

nmol/l

0.18

581

Voice disturbances

618

1.54

3.97

1.7

1.79

5.30

nmol/l

2.66

508

Assault

311

1.77

3.96

1.6

2.55

4.91

nmol/l

0.71

239

Other and unspecified mood [affective] disorders

150

2.14

3.95

1.7

1.6

2.00

3.64

nmol/l

0.56

117

Focal epilepsy, strict definition

417

1.66

3.92

1.4

1.6

2.88

6.64

nmol/l

1.35

329

Dental caries, including avohilmo

229

880

1.33

3.91

1.7

1.6

7.45

6.32

nmol/l

0.11

186

730

Iron deficiency anaemia secondary to blood loss (chronic)

305

1.78

3.91

1.4

1.6

2.54

7.53

nmol/l

1.52

244

Visual field defects

151

2.13

3.89

1.4

1.6

2.18

7.95

nmol/l

1.13

125

AV-block

228

1.84

3.88

1.8

1.7

2.51

7.70

nmol/l

1.73

193

Malignant neoplasm of prostate, including Hilmo

214

1.74

3.87

1.3

1.9

11.57

13.39

nmol/l

0.05

189

Ulcer of lower limb, not elsewhere classified

255

1.85

3.87

1.7

1.6

2.64

8.96

nmol/l

1.81

215

Other mental disorders due to brain damage and dysfunction and to physical disease

192

1.99

3.86

1.8

1.7

1.50

10.12

nmol/l

2.05

161

Unstable angina pectoris

466

1.55

3.86

1.7

1.6

55.76

11.14

nmol/l

0.40

405

Diseases of pulp and periapical tissues and dental caries

203

769

1.36

3.86

1.7

1.6

8.77

6.72

nmol/l

0.19

163

636

Nontoxic single thyroid nodule

145

2.15

3.86

2.1

1.6

4.22

3.87

nmol/l

0.06

117

Endometriosis ASRM stages 1,2

450

1.63

3.85

1.4

1.7

1.60

15.20

nmol/l

0.58

360

Fall on and from stairs and steps

623

1.53

3.85

1.6

1.7

2.75

8.93

nmol/l

0.88

508

Other and unspecified visual disturbances

221

1.91

3.81

1.3

1.6

1.81

7.93

nmol/l

1.70

175

Impingement syndrome of shoulder

460

1.61

3.78

1.6

1.7

2.72

10.29

nmol/l

0.82

384

Other disorders of ear

308

1572

1.27

3.77

1.7

1.6

3.39

8.69

nmol/l

0.80

246

1312

Somnolence, stupor and coma

2.74

3.75

1.3

1.8

7.24

11.40

nmol/l

0.21

Hypermetropia

160

2.07

3.75

1.5

1.7

1.56

4.05

nmol/l

1.04

132

Viral infections of the central nervous system

147

2.12

3.74

1.5

1.8

1.30

4.38

nmol/l

1.20

118

Benign neoplasm: Colon, unspecified

477

1.60

3.73

1.4

1.6

2.47

6.46

nmol/l

2.12

405

Urolithiasis

636

1.51

3.72

1.6

2.63

9.55

nmol/l

1.09

523

Mental and behavioural disorders due to alcohol, excluding acute intoxication

134

939

1.42

3.71

1.5

1.6

43.71

7.27

nmol/l

0.43

108

774

Complications of labour and delivery

146

1126

0.72

3.71

1.9

1.6

1.67

2.81

nmol/l

2.61

116

913

Adenomyosis (Endometriosis of uterus)

273

1.80

3.71

1.3

1.7

1.49

4.20

nmol/l

2.04

240

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

114

783

1.46

3.70

1.7

1.6

3.29

6.42

nmol/l

0.46

636

Fibroblastic disorders

424

1.63

3.70

1.6

1.7

6.72

11.00

nmol/l

0.28

354

Alcohol use disorder, ICD-based

125

874

1.43

3.69

1.4

1.7

47.42

7.49

nmol/l

0.44

720

Lateral epicondylitis

267

1.80

3.68

1.4

1.8

1.66

14.61

nmol/l

0.79

216

Other disorders of bladder

203

1.93

3.66

1.5

1.7

3.66

10.11

nmol/l

1.12

170

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

240

1691

1.29

3.66

1.5

1.6

4.28

8.16

nmol/l

0.50

200

1387

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

2.70

3.66

1.2

2.3

1.86

8.22

nmol/l

1.24

Other gastritis (incl. Duodenitis)

418

1.63

3.64

1.6

7.39

5.19

nmol/l

0.26

339

Radial styloid tenosynovitis [de Quervain]

116

2.25

3.64

1.8

1.7

1.92

4.72

nmol/l

0.96

Problems related to lifestyle

232

1.86

3.63

1.3

1.6

1.77

5.20

nmol/l

0.97

185

Other acute lower respiratory infections

174

1227

1.35

3.63

1.7

1.6

4.64

9.98

nmol/l

0.55

140

1021

Acetic acid derivatives and related substances

245

1.63

3.63

1.6

1.7

9.68

11.78

nmol/l

0.07

209

Candidiasis

335

1.71

3.62

1.8

1.6

5.48

5.80

nmol/l

0.05

265

Other specified/unspecified arthritis

584

1.53

3.62

1.6

2.98

7.85

nmol/l

0.61

486

Pre-eclampsia or eclampsia

569

1.53

3.60

1.6

1.7

2.57

11.95

nmol/l

0.51

471

Injuries to the hip and thigh

148

958

1.39

3.59

1.9

1.6

4.19

6.99

nmol/l

0.52

123

797

Other bacterial intestinal infections

351

1.69

3.59

2.0

1.7

4.48

7.48

nmol/l

0.69

286

Abnormal findings on antenatal screening of mother

226

1.87

3.58

1.9

1.6

1.47

1.38

nmol/l

0.07

176

Other disorders of conjunctiva

262

1.80

3.58

2.0

1.7

3.87

8.24

nmol/l

0.86

212

Cellulitis

514

1.56

3.58

1.7

2.66

10.55

nmol/l

0.93

411

Lung cancer and mesothelioma

246

1.76

3.54

1.4

1.7

15.91

3.86

nmol/l

0.72

209

Conjunctivitis (acute, non atopic)

103

697

1.47

3.54

1.5

1.7

3.52

7.70

nmol/l

0.54

567

Benign paroxysmal vertigo

652

1.49

3.53

1.4

1.7

6.57

4.39

nmol/l

0.30

539

Chronic pancreatitis

220

1.87

3.53

1.7

1.6

2.47

8.16

nmol/l

1.40

192

Other or unspecified ileus, impaction or obstruction

300

1.74

3.53

1.5

1.7

3.80

6.30

nmol/l

0.71

248

Special screening examination for infectious and parasitic diseases

349

1.59

3.52

1.7

1.5

4.14

4.97

nmol/l

0.12

277

Respiratory insufficiency

111

2.25

3.52

2.1

1.9

4.64

4.58

nmol/l

0.01

Urticaria and erythema

134

959

1.40

3.49

1.6

1.7

1.81

12.16

nmol/l

1.05

111

788

Delirium, not induced by alcohol and other psychoactive substances

185

1.95

3.49

1.8

1.7

2.98

9.74

nmol/l

1.34

158

Malignant neoplasm of digestive organs, including Hilmo

116

590

1.45

3.48

1.6

1.7

5.42

7.70

nmol/l

0.23

487

Cardiac murmurs and other cardiac sounds

191

1.92

3.45

1.7

1.6

1.34

7.50

nmol/l

1.47

152

Coagulation defects, purpura and other haemorrhagic conditions

448

1.59

3.44

2.4

1.7

6.29

6.28

nmol/l

0.00

358

Fenamates

172

1.82

3.44

1.6

1.8

1.57

15.99

nmol/l

0.55

147

Benign lipomatous neoplasm

648

1.48

3.43

1.5

1.7

3.37

8.65

nmol/l

0.74

538

Abscess of anal and rectal regions

166

2.00

3.43

1.5

1.8

6.53

4.81

nmol/l

0.17

137

Cervicocranial syndrome

201

1.90

3.42

1.6

1.7

4.96

5.92

nmol/l

0.11

160

Calculus of kidney and ureter

608

1.50

3.42

1.6

2.73

9.93

nmol/l

1.07

497

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

206

1514

1.30

3.39

1.8

1.6

3.70

8.42

nmol/l

0.63

165

1245

Viral infections of the central nervous system, including avohilmo

167

1.99

3.38

1.5

1.8

6.95

4.14

nmol/l

0.20

131

Atopic dermatitis, strict definition with reimbursement

119

806

1.42

3.38

1.5

1.7

4.34

6.81

nmol/l

0.32

652

Dislocation, sprain and strain of joints and ligaments of knee

219

1534

1.29

3.34

1.6

1.7

2.22

8.90

nmol/l

1.10

173

1273

Other benign neoplasms of skin

119

843

1.41

3.32

1.6

5.66

6.94

nmol/l

0.12

105

695

Cardiomyopathy

291

1.72

3.31

1.4

1.7

7.70

14.97

nmol/l

0.36

243

Other juvenile arthritis

2.48

3.30

1.6

1.8

1.38

1.58

nmol/l

0.18

Viral infections characterized by skin and mucous membrane lesions

141

1029

1.37

3.28

1.6

3.72

6.29

nmol/l

0.45

111

847

Other disorders of the musculoskeletal system and connective tissue

315

1.69

3.27

1.4

1.7

9.96

5.23

nmol/l

0.25

254

Endometriosis ASRM stages 3,4

575

1.50

3.25

1.5

1.7

1.89

12.78

nmol/l

0.62

469

Sensorineural hearing loss

223

1153

1.29

3.24

1.7

1.6

2.44

6.39

nmol/l

1.17

182

967

Childhood asthma (age<16), excluding more controls

215

1.75

3.23

1.5

1.6

5.02

1.57

nmol/l

0.51

170

Conductive and sensorineural hearing loss

239

1242

1.28

3.23

1.7

1.6

2.53

6.05

nmol/l

1.10

192

1041

Urticaria

111

781

1.42

3.22

1.5

1.7

1.59

10.47

nmol/l

0.70

634

Early lumbar disc prolapse, operated

220

1.82

3.22

1.6

1.7

5.80

13.11

nmol/l

0.26

171

Gout, FINNGEN

485

1.54

3.20

1.4

1.6

6.46

11.07

nmol/l

0.36

421

Recurrent aphthous stomatitis , including avohilmo

340

1.65

3.20

1.6

3.08

5.96

nmol/l

0.79

269

Postprocedural disorders of nervous system

178

1.92

3.19

1.4

1.6

2.36

2.59

nmol/l

0.07

130

Dermatophytosis, including avohilmo

219

1676

1.28

3.18

1.6

3.66

8.23

nmol/l

0.68

182

1395

Female infertility

106

438

1.45

3.17

1.5

1.7

1.48

3.23

nmol/l

2.08

377

Speech and linguistic disorders

198

1.85

3.16

1.9

1.6

1.61

2.80

nmol/l

0.53

150

Systemic connective tissue disorders

112

794

1.41

3.13

1.6

1.7

5.08

4.59

nmol/l

0.08

662

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

221

1341

1.28

3.12

1.6

1.7

3.33

7.45

nmol/l

0.50

185

1108

Pollen allergy

516

1.51

3.12

1.7

2.02

2.58

nmol/l

0.31

409

Other diseases of the respiratory system

358

1.62

3.11

2.0

1.6

6.11

7.19

nmol/l

0.17

299

Other respiratory disorders and diseases

358

1.62

3.11

2.0

1.6

6.11

7.19

nmol/l

0.17

299

Ocular pain

201

1.85

3.11

1.5

1.7

6.21

4.01

nmol/l

0.19

155

Certain disorders involving the immune mechanism

421

1.57

3.10

1.5

1.7

4.59

6.38

nmol/l

0.40

345

Congenital malformations, deformations and chromosomal abnormalities

216

1602

1.28

3.10

1.6

2.77

8.71

nmol/l

0.96

181

1307

Superficial injury of lower leg

622

1.47

3.10

1.4

1.7

1.73

8.44

nmol/l

1.01

502

Benign neoplasm of ovary

382

1.60

3.10

1.5

1.6

3.53

3.77

nmol/l

0.04

301

Childhood asthma (age<16)

218

1.72

3.09

1.5

1.6

5.02

1.58

nmol/l

0.51

173

Keratitis

121

872

1.39

3.08

1.4

1.6

4.21

7.03

nmol/l

0.41

712

Other disorders of eye and adnexa

344

1.63

3.07

1.4

1.7

5.14

5.78

nmol/l

0.07

268

Injuries to the neck

558

1.49

3.07

1.6

2.43

9.52

nmol/l

0.90

448

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

424

1.56

3.06

1.5

1.8

13.07

3.77

nmol/l

1.31

350

Supervision of normal pregnancy

455

0.60

3.06

1.6

1.90

2.43

nmol/l

0.30

356

Benign neoplasm of middle ear and respiratory system

132

2.05

3.06

2.3

1.7

3.12

9.14

nmol/l

0.91

113

Mental disorders, not otherwise specified

195

1.85

3.06

1.6

1.7

5.90

3.96

nmol/l

0.17

147

Gonarthrosis,primary

268

1291

1.25

3.04

1.7

1.6

2.63

6.40

nmol/l

1.26

224

1086

Presence of other functional implants

165

850

1.33

3.03

1.6

3.78

7.94

nmol/l

0.74

138

715

Sicca syndrome [Sjögren]

182

1.88

3.00

1.5

1.7

1.90

5.68

nmol/l

1.64

143

Inflammatory diseases of the central nervous system

168

1.91

2.99

1.9

1.8

4.09

6.79

nmol/l

0.36

138

Other disorders of glucose regulation and pancreatic internal secretion

161

1.93

2.99

1.8

7.83

7.04

nmol/l

0.06

130

Other and unspecified tonsillitis

121

726

1.39

2.98

1.7

2.16

13.76

nmol/l

0.82

593

Injury of eye and orbit

309

1.66

2.96

1.2

1.6

10.97

5.67

nmol/l

0.27

242

Pain associated with micturition

249

1.73

2.95

1.5

1.7

1.24

3.76

nmol/l

1.80

196

Malignant neoplasm of digestive organs

102

547

1.43

2.93

1.6

1.7

5.78

8.12

nmol/l

0.21

451

Other disorders of nervous system

121

2.08

2.92

1.7

1.6

2.38

8.78

nmol/l

0.93

101

Other systemic involvement of connective tissue

622

1.45

2.92

1.6

1.7

5.57

5.28

nmol/l

0.04

508

Dislocation, sprain and strain of joints and ligaments at neck level

389

1.57

2.89

1.6

1.7

2.31

4.86

nmol/l

0.82

304

Atopic dermatitis, strict definition

115

813

1.39

2.89

1.6

1.7

4.45

13.08

nmol/l

0.60

652

Follicular cysts of skin and subcutaneous tissue

405

1.56

2.89

1.5

1.6

78.13

12.67

nmol/l

0.40

321

Benign neoplasm of meninges

199

1.82

2.89

2.0

1.7

7.97

4.21

nmol/l

0.44

162

Fracture of femur

443

1.51

2.88

1.7

4.00

6.29

nmol/l

0.63

378

Heterophoria

192

1.83

2.88

1.6

1.64

3.99

nmol/l

1.10

150

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

146

1084

1.33

2.86

1.5

1.6

2.59

10.97

nmol/l

0.90

114

880

Injuries to the wrist and hand

353

1942

1.21

2.85

1.6

19.34

4.73

nmol/l

0.49

296

1601

Glomerular diseases

367

1.58

2.85

1.8

1.7

2.67

7.37

nmol/l

1.81

299

Neuromuscular dysfunction of bladder

164

1.90

2.84

1.5

1.7

2.03

12.14

nmol/l

1.81

133

Allergic conjunctivitis

214

1630

1.26

2.83

1.8

1.6

3.58

8.10

nmol/l

0.65

173

1338

Other noninfective gastroenteritis and colitis

568

1.46

2.83

1.5

1.7

8.86

5.08

nmol/l

0.61

457

Perineal laceration during delivery

473

0.56

2.82

1.2

1.7

175.65

2.52

nmol/l

0.48

373

Dissociative [conversion] disorders

2.35

2.82

1.6

1.8

11.62

4.88

nmol/l

0.28

Other bacterial intestinal infections, including avohilmo

512

1.49

2.82

1.9

1.7

7.22

5.83

nmol/l

0.16

414

Acute pharyngitis

349

1.59

2.81

2.3

1.6

4.67

10.15

nmol/l

0.32

281

Pre-eclampsia

529

1.48

2.80

1.6

1.7

2.72

12.69

nmol/l

0.50

437

Other neurotic disorders

2.27

2.77

1.3

1.7

2.13

5.88

nmol/l

0.77

Noninfective enteritis and colitis

153

1164

1.31

2.76

1.5

1.7

5.71

5.82

nmol/l

0.02

126

957

Acute nasopharyngitis (common cold)

230

1.73

2.75

1.4

1.7

1.85

14.32

nmol/l

0.64

191

Mental and behavioural disorders due to sedatives or hypnotics

145

1.94

2.75

1.7

1.8

2.04

4.43

nmol/l

0.78

118

Other diseases of blood and blood-forming organs, wide

483

1.49

2.73

1.7

7.13

5.97

nmol/l

0.12

392

Exposure to other specified factors

280

1967

1.22

2.72

1.5

1.6

4.03

7.55

nmol/l

0.54

232

1627

In situ neoplasms

124

919

1.35

2.71

1.5

1.7

2.46

4.31

nmol/l

1.37

105

767

Focal epilepsy, mode (most common among epilepsy diagnosis)

397

1.54

2.67

1.4

1.6

2.54

6.90

nmol/l

1.59

309

Gout, strict definition

303

1.62

2.66

1.5

1.7

7.05

7.30

nmol/l

0.02

266

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

154

1.89

2.65

1.9

1.8

2.72

3.10

nmol/l

0.10

121

Salpingitis and oophoritis

398

1.54

2.65

1.6

1.7

1.40

3.41

nmol/l

2.40

319

Retinal haemorrhage

3.17

2.65

1.2

1.9

1.85

1.07

nmol/l

0.93

Gout, idiopatic and unspecified

414

1.52

2.65

1.5

1.6

7.24

12.31

nmol/l

0.34

357

Abnormalities of gait and mobility

235

1.71

2.64

1.4

1.7

1.78

9.08

nmol/l

2.12

198

Other diseases of peritoneum

2.22

2.64

1.6

1.8

3.89

6.20

nmol/l

0.34

Non-small cell lung cancer, including Hilmo

213

1.72

2.63

1.4

1.9

4.05

4.93

nmol/l

0.19

177

Open wound of head

159

1151

1.30

2.63

1.5

1.7

3.26

6.13

nmol/l

0.68

130

964

Single spontaneous delivery

707

0.72

2.62

1.8

1.6

4.19

3.40

nmol/l

0.24

572

Other/unspecified synovitis and tenosynovitis

236

1.70

2.60

1.6

1.7

1.68

6.69

nmol/l

1.45

186

Disorders of tooth development and eruption

291

1.57

2.59

1.5

1.7

5.62

12.62

nmol/l

0.38

243

Pediculosis, acariasis and other infestations, including avohilmo

433

1.50

2.57

1.8

1.7

2.91

4.48

nmol/l

0.58

343

Bacterial intestinal infections, IBD co-morbidities

377

1.54

2.57

2.0

1.7

4.52

6.88

nmol/l

0.52

306

Panic disorder

378

1.54

2.55

1.6

1.7

1.06

3.15

nmol/l

2.34

299

Other abnormal uterine and vaginal bleeding

367

1.47

2.54

1.6

1.7

3.26

4.04

nmol/l

0.30

323

Paracetamol or NSAID medication

123

1.73

2.54

1.8

1.6

5.66

22.29

nmol/l

0.39

100

Appendectomy

225

1730

1.24

2.54

1.5

1.6

3.23

8.01

nmol/l

0.75

185

1426

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

509

1.46

2.51

1.8

1.7

83.48

2.66

nmol/l

0.50

411

Diseases of middle ear and mastoid

207

1353

1.25

2.50

1.8

1.6

4.28

9.30

nmol/l

0.54

172

1107

Disease of hard tissues of teeth, NOS

155

621

1.31

2.48

1.6

5.01

8.22

nmol/l

0.31

129

522

Pre-eclampsia or poor fetal growth

119

886

1.34

2.48

1.5

1.7

2.17

8.61

nmol/l

0.54

727

Endometriosis of rectovaginal septum and vagina

158

1.84

2.47

1.4

1.7

2.57

5.40

nmol/l

0.91

137

Other diseases of hard tissues of teeth

157

624

1.30

2.47

1.6

7.65

8.18

nmol/l

0.04

120

525

Pedal cyclist injured in transport accident

536

1.44

2.46

1.7

1.6

1.93

9.74

nmol/l

1.00

429

Graves disease, strict definition

248

1.66

2.46

1.9

1.7

5.61

3.99

nmol/l

0.17

185

Coxarthrosis, primary

159

1027

1.29

2.44

1.5

1.6

4.48

6.84

nmol/l

0.44

129

873

Fracture of foot, except ankle

621

1.40

2.43

1.8

1.7

1.86

8.71

nmol/l

1.03

500

Abnormal findings in secretions and smears from cervix uteri vagina vulva

194

1137

1.26

2.42

1.7

3.45

7.28

nmol/l

0.36

160

924

Other condition

335

1.56

2.42

1.6

5.91

6.11

nmol/l

0.02

260

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

288

1.60

2.41

1.5

1.7

4.41

5.81

nmol/l

0.19

233

Meniscus derangement

158

813

1.29

2.41

1.6

2.06

13.67

nmol/l

1.01

127

682

Aortic valve malfunction, age under 60 years

189

1.75

2.40

1.6

1.7

2.86

20.06

nmol/l

0.75

157

Later onset COPD

325

1.51

2.40

1.5

1.6

5.51

7.37

nmol/l

0.29

280

Diseases of appendix

248

1820

1.22

2.40

1.6

3.11

7.89

nmol/l

0.82

207

1507

Anti-inflammatory and antirheumatic products, non-steroids

265

1.46

2.40

1.7

3.86

11.05

nmol/l

0.37

224

Enthesopathies of lower limb, excluding foot

473

1.46

2.40

1.8

1.6

3.79

9.87

nmol/l

0.55

397

Hallux valgus (acquired)

102

532

1.37

2.39

1.6

2.76

3.98

nmol/l

0.55

448

Injuries to the shoulder and upper arm

274

1751

1.21

2.38

1.6

4.48

8.08

nmol/l

0.49

221

1457

Organic, including symptomatic, mental disorders

133

711

1.32

2.38

1.7

1.6

4.29

5.72

nmol/l

0.38

113

616

Ganglion

466

1.46

2.37

1.5

1.7

2.48

9.94

nmol/l

0.79

379

Periapical abscess

148

1150

1.29

2.37

1.6

1.7

6.08

5.80

nmol/l

0.03

119

952

Plantar fascial fibromatosis

205

1.71

2.37

1.5

1.8

1.41

7.54

nmol/l

1.70

162

Scabies, including avohilmo

385

1.51

2.36

1.7

2.98

2.77

nmol/l

0.09

301

Benign neoplasm: Ascending colon

274

1.61

2.36

1.5

1.7

2.96

8.51

nmol/l

1.49

231

Alcohol abuse, main dg

337

1.55

2.36

1.7

1.6

5.03

14.21

nmol/l

0.60

263

Malignant neoplasm of small intestine

3.05

2.36

1.3

2.1

3.83

7.23

nmol/l

—

Social phobias

198

1.72

2.34

1.5

1.6

0.97

3.66

nmol/l

1.58

161

Unspecified urinary incontinence

176

1.77

2.33

1.5

1.7

1.70

4.11

nmol/l

1.15

143

Other inflammation of eyelid

323

1.55

2.31

1.4

1.7

8.00

4.27

nmol/l

0.37

257

Other maternal disorders predominantly related to pregnancy

214

1082

1.24

2.31

1.7

1.75

3.08

nmol/l

2.46

165

886

All influenza

527

1.42

2.30

1.7

1.6

2.84

9.43

nmol/l

0.77

427

Strabismus

643

1.38

2.30

1.5

1.7

4.95

4.87

nmol/l

0.01

519

Aneurysms, operations, SAH

316

1.55

2.28

1.9

1.7

8.44

7.35

nmol/l

0.07

260

Appendicitis, broad definition

245

1813

1.21

2.28

1.6

3.13

7.91

nmol/l

0.81

205

1503

Primary adrenocortical insufficiency

3.52

2.28

3.8

1.6

15.64

9.85

nmol/l

—

Dysplasia of cervi uteri

409

1.41

2.28

1.7

1.83

3.35

nmol/l

1.39

351

Disorders of muscles

200

1.70

2.27

1.4

1.6

2.34

7.61

nmol/l

1.22

157

Gestational diabetes (for exclusion)

150

803

1.29

2.27

1.7

35.93

2.80

nmol/l

0.47

126

645

Maternal care for other conditions predominantly related to pregnancy

582

1.39

2.24

1.4

1.7

1.39

2.86

nmol/l

1.71

471

Mixed disorders of conduct and emotions, excluding more controls

3.12

2.23

2.1

1.6

1.13

2.02

nmol/l

—

Suppurative and necrotic conditions of lower respiratory tract

2.10

2.22

1.4

1.7

2.92

10.81

nmol/l

0.79

Diseases of peritoneum

194

1.71

2.22

1.6

1.8

6.06

7.45

nmol/l

0.15

158

Zoster [herpes zoster], including avohilmo

156

1188

1.27

2.21

1.6

3.53

6.36

nmol/l

0.63

124

993

Dystonia

121

1.91

2.21

1.7

1.6

8.86

4.25

nmol/l

0.27

Anorexia (incl.atypical)

128

1.88

2.20

1.4

1.8

1.51

3.38

nmol/l

0.61

101

Liquid cancers, including Hilmo

602

1.36

2.19

1.6

1.7

5.73

7.44

nmol/l

0.14

494

Other disorders of male genital organs

2.51

2.18

1.1

1.6

5.26

2.05

nmol/l

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

203

1.68

2.17

1.6

1.7

2.79

18.89

nmol/l

0.75

169

Fracture of shoulder and upper arm

109

823

1.32

2.16

1.7

1.6

3.95

6.77

nmol/l

0.42

677

Benign neoplasm of mouth and pharynx

211

1.66

2.16

1.5

1.7

3.37

7.57

nmol/l

0.84

175

Sequelae of injuries of lower limb

196

1.69

2.15

1.4

1.7

1.39

6.04

nmol/l

1.16

155

Cardiomyopathies, Primary/intrinsic

196

1.69

2.15

1.4

1.8

10.59

8.34

nmol/l

0.12

164

Cardiomyopathy (excluding other)

204

1.67

2.13

1.4

1.8

10.32

7.98

nmol/l

0.13

172

Diseases of external ear

109

826

1.32

2.13

1.7

2.63

7.45

nmol/l

0.94

677

Other strabismus

542

1.40

2.13

1.5

1.7

4.30

4.38

nmol/l

0.01

434

Idiopathic gout

137

1.83

2.13

1.6

1.8

1.86

10.28

nmol/l

1.34

120

Chronic conjunctivitis

2.38

2.12

1.8

1.9

6.02

4.92

nmol/l

0.08

Symptoms and signs involving emotional state

2.38

2.12

2.0

1.8

2.48

5.47

nmol/l

0.40

Gestational [pregnancy-induced] hypertension

724

1.34

2.08

1.9

1.7

5.44

9.87

nmol/l

0.24

590

Other and unspecified urticaria

488

1.42

2.08

1.5

1.7

1.44

4.54

nmol/l

2.05

388

Small fibre neuropathy

2.57

2.08

1.5

2.0

2.65

5.65

nmol/l

0.31

Acute bronchitis

121

916

1.30

2.07

1.5

1.6

2.60

6.90

nmol/l

0.91

750

Striking against or struck by other objects

113

864

1.31

2.06

1.4

1.6

51.83

7.01

nmol/l

0.47

697

Diseases of the myoneural junction and muscle

245

1.60

2.06

1.6

1.7

3.35

6.96

nmol/l

0.75

203

Oter anti-inflammatory and antirheumatic agents, non-steroids

183

1.53

2.06

1.6

1.7

4.70

14.99

nmol/l

0.39

160

Early lumbar disc prolapse operation

269

1.57

2.05

1.5

1.6

5.53

11.73

nmol/l

0.26

205

Other noninflammatory disorders of vulva and perineum

222

1.63

2.05

1.6

1.8

3.27

4.40

nmol/l

0.22

193

Mixed hyperlipidaemia

2.41

2.02

1.9

1.8

2.04

12.60

nmol/l

0.68

Adjustment and management of implanted device

286

1.54

2.02

1.5

1.6

7.25

6.59

nmol/l

0.05

243

Disorders of puberty

3.10

2.02

2.3

1.4

22.14

0.92

nmol/l

—

Suppurative and unspecified otitis media

130

900

1.28

2.01

1.9

1.6

2.41

6.85

nmol/l

0.93

103

729

Gout, unspecified

343

1.49

2.00

1.5

1.7

8.34

7.60

nmol/l

0.05

303

Juvenile arthritis (FINNGEN)

104

1.93

2.00

1.6

2.0

1.38

3.57

nmol/l

0.54

Malignant neoplasm of tongue, including Hilmo

2.83

2.00

2.1

2.2

2.74

8.34

nmol/l

—

D07AA Corticosteroids, weak (group I)

367

1.47

2.00

1.8

1.6

4.99

4.45

nmol/l

0.09

279

Hypertrophy of breast

442

1.43

2.00

1.4

1.7

3.54

3.04

nmol/l

0.09

351

Open wound of lower leg

327

1.50

2.00

1.4

1.6

2.14

6.84

nmol/l

1.56

260

Other superficial mycoses, including avohilmo

271

1.55

2.00

1.8

1.6

6.16

4.84

nmol/l

0.10

212

Coeliac disease

271

1.55

1.99

1.5

1.7

3.62

6.77

nmol/l

0.70

211

Superficial injury of abdomen, lower back and pelvis

368

1.47

1.99

1.5

1.6

2.85

4.42

nmol/l

0.39

292

All influenza (not pneumonia)

287

1.54

1.99

1.7

3.21

6.51

nmol/l

0.70

227

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

393

1.45

1.98

1.8

1.6

8.93

5.69

nmol/l

0.18

314

Spontaneous rupture of synovium and tendon

148

1.76

1.98

1.5

1.6

1.46

9.63

nmol/l

1.70

122

Other inflammation of eyelid, including avohilmo

156

1252

1.25

1.97

1.8

1.6

4.50

9.36

nmol/l

0.49

129

1024

Scoliosis

186

1.67

1.97

1.9

1.6

1.92

2.67

nmol/l

0.54

145

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

329

1.45

1.96

1.4

1.8

14.45

4.18

nmol/l

0.70

279

Injury of muscle and tendon at shoulder and upper arm level

716

1.33

1.96

1.6

1.7

6.61

8.02

nmol/l

0.10

600

Persons with potential health hazards related to communicable diseases

137

1075

1.26

1.95

1.6

1.7

1.76

11.41

nmol/l

1.10

114

873

Other viral diseases, not elsewhere classified, including avohilmo

705

1.33

1.92

1.9

1.6

4.94

7.12

nmol/l

0.22

563

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

180

1.67

1.91

1.7

2.30

7.63

nmol/l

1.16

149

Acute alcohol intoxication

539

1.37

1.91

1.6

4.16

9.77

nmol/l

0.59

434

Malignant neoplasm of respiratory system and intrathoracic organs

293

1.47

1.91

1.4

1.8

15.96

4.42

nmol/l

0.70

247

Benign leiomyoma with endometriosis

331

1.48

1.90

1.3

1.8

1.78

4.43

nmol/l

2.26

266

Pustulosis palmaris et plantaris

2.01

1.90

1.9

1.8

2.55

4.14

nmol/l

0.29

Benign neoplasm: Cerebral meninges

188

1.65

1.90

2.0

1.7

5.35

4.93

nmol/l

0.05

154

Use of interferon beta-1a

0.00

1.88

0.0

2.1

—

2.52

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

348

1.47

1.88

1.8

1.7

9.77

6.11

nmol/l

0.18

274

Primary gonarthrosis, bilateral

139

926

1.26

1.87

1.6

1.59

7.53

nmol/l

1.64

116

787

Acute appendicitis

227

1766

1.19

1.86

1.6

3.26

8.05

nmol/l

0.78

188

1463

Disorders of breast

179

1291

1.22

1.85

1.6

2.45

7.05

nmol/l

0.57

142

1062

Nonischemic cardiomyopathy

159

1.70

1.84

1.3

1.7

2.68

9.89

nmol/l

1.25

135

Diabetic retinopathy, excluding more controls

109

468

1.31

1.84

1.4

1.6

24.24

3.76

nmol/l

0.48

391

Adhesive capsulitis of shoulder

334

1.47

1.83

1.5

1.8

1.54

12.96

nmol/l

0.92

274

682

1.31

1.82

1.5

1.6

4.79

5.71

nmol/l

0.22

582

Uterine polyps

379

1.34

1.80

1.7

2.13

3.95

nmol/l

1.53

333

Haemorrhage in early pregnancy

100

748

1.30

1.79

1.6

1.7

1.69

3.26

nmol/l

2.04

611

Calcific aortic valvular stenosis, operated

451

1.39

1.79

1.5

1.6

6.72

6.50

nmol/l

0.02

390

Calcific aortic valvular stenosis

451

1.39

1.79

1.5

1.6

6.72

6.50

nmol/l

0.02

390

Antenatal screening

469

0.71

1.78

1.6

2.50

2.39

nmol/l

0.04

368

Schizophrenia

345

1.45

1.77

1.6

2.71

12.66

nmol/l

0.74

272

Seropositive rheumatoid arthritis

477

1.38

1.75

1.6

1.95

5.36

nmol/l

1.94

392

Gingival hyperplasia

2.04

1.75

1.9

1.8

3.75

4.43

nmol/l

0.08

Umbilical hernia

574

1.34

1.75

1.7

1.6

83.10

8.62

nmol/l

0.50

466

Rheumatoid arthritis

591

1.32

1.74

1.6

2.40

7.90

nmol/l

0.75

496

Ankylosing spondylitis

162

1.67

1.74

1.3

1.6

2.43

6.82

nmol/l

0.77

129

Pterygium

2.51

1.74

1.9

2.1

3.01

7.11

nmol/l

—

Dislocation, sprain and strain of joints and ligaments of elbow

147

1.71

1.73

1.8

1.7

7.16

2.34

nmol/l

0.48

115

Herpesviral [herpes simplex] infections, including avohilmo

670

1.32

1.73

1.7

4.07

3.77

nmol/l

0.05

548

Liquid cancers

511

1.35

1.73

1.6

1.7

6.81

8.18

nmol/l

0.09

417

Toxic effect of carbon monoxide

2.94

1.72

1.1

2.0

1.31

9.22

nmol/l

—

Convalescence

103

1.85

1.71

1.3

1.8

8.19

3.52

nmol/l

0.30

Pyothorax

2.14

1.71

1.5

1.7

2.89

11.03

nmol/l

—

Pedal cyclist injured in noncollision transport accidents

266

1.51

1.70

1.8

1.7

1.58

5.52

nmol/l

1.33

206

Disorders of optic nerve and visual pathways

210

1.58

1.70

1.5

1.6

5.17

5.38

nmol/l

0.02

161

Delivery

106

714

0.78

1.70

1.8

1.6

4.23

3.39

nmol/l

0.28

579

Other diseases of pleura

108

735

1.28

1.69

1.7

5.06

8.55

nmol/l

0.50

623

Labour and delivery complicated by fetal stress [distress]

538

0.72

1.69

1.6

1.7

4.29

1.75

nmol/l

0.51

424

Alcohol dependence

526

1.35

1.69

1.5

1.6

81.38

9.90

nmol/l

0.43

433

Skin changes due to chronic exposure to nonionizing radiation

640

1.30

1.68

1.5

1.6

4.98

5.93

nmol/l

0.22

549

Benign neoplasm: Transverse colon

203

1.58

1.67

1.4

1.7

2.48

9.74

nmol/l

1.61

172

Cardiomyopathy, other and unspecified

126

1.75

1.67

1.1

1.9

13.02

10.43

nmol/l

0.09

111

Deep endometriosis

235

1.54

1.67

1.4

1.7

2.36

4.19

nmol/l

0.79

183

Biomechanical lesions, not elsewhere classified

104

1.83

1.67

1.2

1.8

1.34

5.54

nmol/l

1.26

Rosacea

292

1.48

1.66

1.6

1.7

1.66

6.28

nmol/l

1.68

227

Tinnitus

519

1.35

1.66

1.5

1.7

2.74

5.33

nmol/l

0.90

436

Calcific aortic valvular stenosis, diagnosis (helper)

450

1.37

1.65

1.5

1.6

6.83

6.52

nmol/l

0.03

389

Operations 2 for CAVS

450

1.37

1.65

1.5

1.6

6.83

6.52

nmol/l

0.03

389

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

2.82

1.65

2.3

2.2

5.43

11.03

nmol/l

—

Small cell lung cancer, helper endpoint

2.81

1.65

1.3

1.8

77.64

9.20

nmol/l

—

Polyp of the female genital tract

393

1.31

1.64

1.7

2.00

3.88

nmol/l

1.75

345

Acute alcohol intoxication, ICD10

452

1.37

1.64

1.6

4.55

11.13

nmol/l

0.56

357

Other viral diseases, including avohilmo

131

1047

1.24

1.63

1.8

1.6

4.23

11.58

nmol/l

0.67

111

849

Other and unspecified myopathies

150

1.67

1.63

1.6

1.7

4.81

9.76

nmol/l

0.62

126

Melanocytic naevi, other sites/unspecified

189

1.59

1.62

1.6

1.7

2.15

6.23

nmol/l

0.87

149

Infections with a predominantly sexual mode of transmission, including avohilmo

147

1099

1.22

1.62

1.4

1.7

2.42

10.62

nmol/l

0.89

114

895

Maternal care for known or suspected fetal abnormality and damage

434

0.66

1.62

1.2

1.6

2.22

14.67

nmol/l

0.50

351

Restless leg syndrome

319

1.45

1.61

1.6

1.7

3.63

6.31

nmol/l

0.66

254

Fissure and fistula of anal and rectal regions

479

1.36

1.61

1.3

1.7

1.80

9.73

nmol/l

0.90

388

Postprocedural disorders of digestive system, not elsewhere classified

2.15

1.61

1.4

1.9

4.50

4.78

nmol/l

0.03

Calcific aortic valvular stenosis, including rheumatic fever

452

1.36

1.61

1.5

1.6

6.83

6.49

nmol/l

0.03

391

Fracture at wrist and hand level

108

852

1.26

1.60

1.3

1.6

5.08

6.30

nmol/l

0.14

688

Anogenital herpesviral [herpes simplex] infection, including avohilmo

295

1.46

1.59

1.3

1.7

1.82

3.32

nmol/l

0.88

229

Other disorders of skin and subcutaneous tissue, not elsewhere classified

287

1.47

1.59

1.5

1.6

2.93

8.35

nmol/l

1.41

229

Spirochaetal infections, other/unspecified, including avohilmo

835

0.74

1.58

1.5

1.7

3.97

7.27

nmol/l

0.41

686

Viral conjunctivitis

2.29

1.56

1.7

1.8

2.46

6.12

nmol/l

—

Other spirochaetal diseases

833

0.74

1.55

1.5

1.7

3.97

7.28

nmol/l

0.41

685

Sulfasalazine

647

1.30

1.55

1.7

4.01

8.33

nmol/l

0.55

540

Other contact dermatitis

160

1.63

1.55

2.1

1.7

2.76

5.14

nmol/l

0.71

128

Other diseases of oesophagus

160

1.63

1.55

1.5

1.7

2.37

8.35

nmol/l

1.00

137

Unspecified acute lower respiratory infection

322

1.43

1.54

2.4

1.7

2.32

13.75

nmol/l

0.84

257

Fracture of skull and facial bones

483

1.35

1.54

1.6

1.7

3.81

10.12

nmol/l

0.63

389

Chronic ulcer of skin, not elsewhere classified

122

1.73

1.54

1.5

1.7

4.09

11.03

nmol/l

0.88

105

Paranoid personality disorder

2.44

1.54

1.9

1.7

1.01

7.51

nmol/l

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

173

1.60

1.54

1.7

1.8

2.68

3.03

nmol/l

0.07

129

Pustular psoriasis

100

1.81

1.53

1.9

1.7

2.51

5.31

nmol/l

0.61

Other and/or unspecified nontoxic goitre

161

1.62

1.52

1.6

7.12

4.33

nmol/l

0.24

132

Vulvovaginal ulceration/inflammation in other diseases

177

1.59

1.51

1.4

1.7

1.27

4.14

nmol/l

1.22

127

Female genital prolapse

367

1.30

1.50

1.3

1.7

4.74

4.02

nmol/l

0.09

324

Localized swelling, mass and lump of skin and subcutaneous tissue

730

1.28

1.50

1.7

1.6

2.63

7.74

nmol/l

0.84

605

Spondyloarthritis

383

1.39

1.50

1.5

1.6

3.73

4.99

nmol/l

0.28

309

Faecal incontinence

162

1.61

1.49

1.9

1.7

2.49

4.16

nmol/l

0.51

132

Other spirochaetal diseases, including avohilmo

849

0.75

1.48

1.5

1.7

3.86

7.18

nmol/l

0.42

697

Lyme disease, including avohilmo

826

0.75

1.48

1.5

1.7

3.97

7.32

nmol/l

0.41

680

Lyme disease

826

0.75

1.48

1.5

1.7

3.97

7.32

nmol/l

0.41

680

Bell's palsy

226

1.51

1.48

1.2

1.7

3.00

7.13

nmol/l

0.89

177

Contact with and exposure to communicable diseases

111

888

1.25

1.47

1.7

1.6

1.78

12.28

nmol/l

0.93

716

Injury of unspecified body region

147

1.64

1.47

1.3

1.8

2.12

6.58

nmol/l

0.74

117

Acute appendicitis, no complications

178

1491

1.19

1.47

1.7

1.6

2.22

8.98

nmol/l

1.07

150

1228

Speech disturbances, not elsewhere classified

163

1.60

1.46

1.7

9.06

9.05

nmol/l

0.00

138

Other inflammatory liver diseases

132

1.67

1.45

1.5

1.7

1.79

8.02

nmol/l

1.08

110

Other congenital malformations of ear

2.52

1.45

1.3

1.6

2.30

2.05

nmol/l

—

Myopia

335

1.41

1.45

1.7

1.75

3.32

nmol/l

1.11

258

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

335

1.41

1.45

1.5

1.8

17.32

4.31

nmol/l

0.84

281

Ankylosing spondylitis, strict definition

1.88

1.44

1.3

1.9

1.64

4.56

nmol/l

—

Acute and subacute iridocyclitis

420

1.36

1.44

1.8

1.7

2.42

6.31

nmol/l

1.64

341

Postzoster neuralgia

3.14

1.44

2.6

1.7

1.64

1.38

nmol/l

—

Infections with a predominantly sexual mode of transmission

107

858

1.25

1.43

1.3

1.7

2.32

9.62

nmol/l

0.62

704

Zoster [herpes zoster]

387

1.37

1.42

1.4

1.7

6.13

7.08

nmol/l

0.09

317

Anomalies of dental arch relationship, including avohilmo

482

1.31

1.41

1.7

1.6

4.22

4.16

nmol/l

0.01

378

Obstructed labour due to malposition and malpresentation of fetus

653

0.74

1.41

1.7

1.78

2.57

nmol/l

0.66

515

Malignant neoplasm of bronchus and lung, including Hilmo

294

1.39

1.40

1.4

1.8

16.56

4.41

nmol/l

0.69

249

Cervical polyps

205

1.52

1.40

1.6

1.8

2.09

4.60

nmol/l

1.10

180

Otalgia

181

1.55

1.39

1.3

1.7

2.25

4.32

nmol/l

0.82

142

Malignant neoplasm of bronchus and lung

253

1.42

1.39

1.4

1.9

18.70

4.44

nmol/l

0.72

211

Prolonged pregnancy

442

0.69

1.39

2.1

1.6

1.79

14.47

nmol/l

0.52

356

Spasmodic torticollis

1.95

1.38

1.2

2.0

1.35

7.11

nmol/l

—

Unspecified privation

222

1.49

1.38

2.1

1.8

2.41

7.08

nmol/l

1.16

175

Noninfectious colitis NAS

305

1.41

1.37

1.4

1.7

12.16

5.07

nmol/l

0.71

237

Allergic contact dermatitis due to drugs in contact with skin

2.21

1.37

1.1

2.2

4.42

6.19

nmol/l

—

severe traumatic brain injury, does not include concussion

407

1.35

1.37

1.5

1.7

3.02

6.88

nmol/l

1.32

342

conjunctival haemorrhage

135

1.63

1.35

1.5

1.7

2.66

10.40

nmol/l

1.27

111

Other viral diseases, not elsewhere classified

441

1.34

1.35

1.8

1.7

7.19

10.39

nmol/l

0.19

350

Actinic keratosis

617

1.27

1.35

1.5

1.6

5.28

6.05

nmol/l

0.16

530

Car occupant injured in other and unspecified transport accidents

469

1.32

1.34

1.7

3.84

4.81

nmol/l

0.23

365

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

0.00

1.34

0.0

1.7

—

6.55

—

Acute pancreatitis

375

1.36

1.33

1.7

1.6

4.01

12.40

nmol/l

0.69

315

Acute suppurative otitis media

692

1.25

1.33

1.8

1.6

2.67

7.36

nmol/l

0.68

546

Other fall from one level to another

549

1.29

1.32

1.9

1.6

2.62

9.92

nmol/l

0.91

440

Anterior Iridocyclitis

445

1.33

1.31

1.8

1.7

2.41

6.05

nmol/l

1.61

361

Viral pneumonia

258

1.44

1.31

2.2

1.7

2.52

7.34

nmol/l

1.43

206

Other acute viral hepatitis

2.52

1.30

1.3

1.7

56.87

9.44

nmol/l

—

Dementia due to Parkinson's disease

2.51

1.30

1.7

1.8

2.52

10.11

nmol/l

—

Female infertility, cervical, vaginal, other or unspecified origin

428

1.27

1.30

1.5

1.7

2.09

3.28

nmol/l

0.85

369

Disorders of puberty, all

2.37

1.29

2.3

1.6

22.14

1.08

nmol/l

—

Other problems related to primary support group, including family circumstances

276

1.41

1.29

1.8

1.7

1.91

3.63

nmol/l

0.74

206

Other acute disseminated demyelination

2.80

1.29

1.4

2.4

2.00

1.16

nmol/l

—

Spondylopathies (FG)

301

1.40

1.28

1.4

1.7

2.25

4.41

nmol/l

0.67

237

Maltreatment syndromes

114

1.67

1.28

1.3

1.7

14.41

3.67

nmol/l

0.39

Superficial injuries involving multiple body regions

2.09

1.28

2.2

2.0

2.27

5.55

nmol/l

—

Acute and transient psychotic disorders

260

1.43

1.26

1.6

1.57

5.81

nmol/l

1.41

200

Assault by bodily force

186

1.51

1.26

1.4

1.7

2.33

3.08

nmol/l

0.25

147

Leiomyoma of uterus

206

995

1.16

1.26

1.7

1.6

2.46

8.54

nmol/l

0.59

178

811

Palmar fascial fibromatosis [Dupuytren]

227

1.46

1.26

1.6

1.7

10.51

17.34

nmol/l

0.23

198

Superficial injury of shoulder and upper arm

269

1.42

1.25

1.7

1.69

6.49

nmol/l

1.61

211

Primary ovarian failure

2.23

1.24

3.1

1.4

1.74

2.14

nmol/l

—

Pleural plaque without asbestos

2.23

1.24

1.0

1.8

1.31

6.96

nmol/l

—

Diagnoses used for exclusion with ILD

493

1.30

1.24

1.5

1.7

3.22

5.89

nmol/l

1.03

406

Otitis externa

546

1.28

1.24

1.6

2.71

9.89

nmol/l

0.90

439

Dilated cardiomyopathy

195

1.49

1.24

1.5

1.7

11.55

8.77

nmol/l

0.13

166

Disorders of vitreous body

141

1128

1.19

1.23

1.5

1.7

4.03

6.65

nmol/l

0.51

124

947

Reimbursement for rheumatic diseases

171

1454

1.17

1.23

1.6

2.44

9.20

nmol/l

1.04

135

1207

Benign neoplasm: Skin of eyelid, including canthus

321

1.37

1.22

1.7

11.53

6.30

nmol/l

0.25

261

Crowding of teeth, including avohilmo

202

1.44

1.22

1.9

1.7

1.23

2.97

nmol/l

0.93

154

Melanocytic naevi of trunk

279

1.40

1.22

1.4

1.7

2.01

6.16

nmol/l

1.32

217

Nonsuppurative otitis media, including avohilmo

110

782

1.22

1.21

2.1

1.6

6.10

3.79

nmol/l

0.25

626

Viral warts, including avohilmo

548

1.28

1.21

2.2

1.6

2.65

8.72

nmol/l

0.72

442

Preterm labour and delivery

735

1.24

1.21

1.5

1.6

1.30

2.88

nmol/l

3.59

596

Trigger finger

306

1.37

1.19

1.6

1.7

1.71

6.04

nmol/l

1.80

243

Injuries to unspecified part of trunk, limb or body region

214

1.45

1.17

1.5

1.7

2.33

7.39

nmol/l

1.24

170

Viral haemorrhagic fevers, not elsewhere classified/unspecified

157

1.53

1.17

1.7

20.23

5.53

nmol/l

0.37

132

Disorders of vitreous body and globe

143

1146

1.18

1.16

1.5

1.7

3.99

6.59

nmol/l

0.51

126

959

Otitis externa, unspecified

265

1.40

1.16

1.8

1.7

2.42

5.96

nmol/l

0.99

204

Fasciculation

2.52

1.15

1.0

2.2

1.80

0.95

nmol/l

—

Ankyloglossia

0.00

1.15

0.0

1.6

—

1.31

—

Central retinal artery occlusion

2.51

1.15

1.2

1.9

2.00

1.14

nmol/l

—

Impacted maxillary molar

174

1.50

1.15

1.4

1.6

1.24

2.83

nmol/l

0.67

134

Seronegative rheumatoid arthritis

207

1.45

1.14

2.0

1.8

3.52

7.95

nmol/l

0.69

165

Injuries to the elbow and forearm

227

1709

1.14

1.5

1.6

6.16

7.91

nmol/l

0.18

190

1400

Status post-ami

278

1.34

1.14

1.6

1.5

2.81

8.72

nmol/l

2.02

243

Diabetic neuropathy

307

1.36

1.14

1.8

1.7

3.68

13.40

nmol/l

0.66

258

Iridocyclitis

501

1.28

1.12

1.8

1.7

2.31

5.75

nmol/l

1.75

406

Other peripheral vascular diseases

175

1.49

1.12

1.7

4.83

4.61

nmol/l

0.02

137

Deficiency of other B group vitamins

2.34

1.12

1.4

1.8

2.26

7.91

nmol/l

—

Pemphigoid

2.34

1.12

1.0

1.6

3.36

8.04

nmol/l

—

Superficial injury of ankle and foot

310

1.36

1.11

1.3

1.6

2.05

4.90

nmol/l

0.93

232

Pedal cyclist injured in other and unspecified transport accidents

259

1.39

1.11

1.3

1.7

1.95

6.55

nmol/l

1.40

201

Preparatory care for dialysis

1.79

1.11

2.0

1.7

2.45

4.03

nmol/l

0.27

Malnutrition

2.27

1.10

2.1

1.6

2.12

7.97

nmol/l

—

Excessive vomiting in pregnancy

201

1.45

1.09

1.8

1.7

1.97

4.04

nmol/l

0.77

158

Presbyopia

168

1.49

1.09

1.4

1.7

2.55

4.81

nmol/l

0.72

131

Prominent ears

2.40

1.09

1.4

1.5

2.86

1.15

nmol/l

—

Embedded teeth, including avohilmo

243

1.40

1.09

1.6

1.7

1.42

2.53

nmol/l

0.66

193

Malignant neoplasm of rectosigmoid junction

2.39

1.09

1.2

2.0

17.72

11.66

nmol/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

193

1.45

1.09

1.6

1.7

17.43

5.17

nmol/l

0.37

159

Recurrent dislocation of patella

120

1.59

1.08

1.6

1.5

1.28

1.90

nmol/l

0.57

Personal history of other diseases and conditions

285

1.36

1.07

1.2

1.8

1.97

3.50

nmol/l

0.63

216

Rash and other nonspecific skin eruption

202

1.44

1.07

2.1

1.7

7.40

6.91

nmol/l

0.03

161

Psoriasis vulgaris

408

1.30

1.07

1.5

1.6

4.74

12.27

nmol/l

0.59

327

Chondropathies

356

1.32

1.06

1.4

1.6

4.58

4.88

nmol/l

0.04

276

Dermatophytosis

287

1.36

1.06

1.4

1.7

3.66

8.01

nmol/l

0.89

236

Pathological resorption of teeth

1.71

1.05

1.6

1.8

1.26

3.93

nmol/l

—

Cramp and spasm

1.67

1.04

1.9

1.8

3.47

3.80

nmol/l

—

Thyroiditis

162

1.49

1.04

1.5

1.7

1.47

4.56

nmol/l

1.22

120

Benign neoplasm: Rectum, anus and anal canal

393

1.30

1.03

1.5

1.7

5.47

6.96

nmol/l

0.23

334

Supervision of high-risk pregnancy

437

0.78

1.03

1.5

1.6

1.62

2.48

nmol/l

0.74

342

Other hammer toe(s) (acquired)

286

1.34

1.02

2.2

1.6

1.95

4.50

nmol/l

1.01

240

Isolated patent ductus arteriosus

2.26

1.02

2.0

1.7

2.10

1.14

nmol/l

—

Malignant melanoma, including Hilmo

307

1.34

1.01

1.9

1.8

3.25

4.59

nmol/l

0.35

248

Congenital malformations of heart and great arteries

281

1.35

1.01

1.7

2.34

5.70

nmol/l

1.01

221

Malignant neoplasm of oral cavity

1.88

1.00

2.1

2.2

3.14

9.56

nmol/l

—

Benign neoplasm: Rectum

360

1.31

1.00

1.5

1.7

5.94

7.37

nmol/l

0.20

307

Inflammatory disorders of breast

172

1.46

0.99

2.1

1.7

1.06

3.67

nmol/l

1.31

128

Malignant melanoma

282

1.35

0.99

2.0

1.8

3.48

4.87

nmol/l

0.33

227

False labour

118

618

1.19

0.99

1.7

1.6

1.16

11.43

nmol/l

0.63

504

Corneal ulcer

431

1.28

0.99

1.4

1.7

7.34

11.90

nmol/l

0.29

345

Ankylosing spondylitis, ICD10

189

1.43

0.99

1.3

1.7

2.43

7.16

nmol/l

0.96

155

Atrophic disorders of skin

352

1.31

0.99

1.3

1.6

3.87

3.71

nmol/l

0.03

278

Previous suicide attempt

2.19

0.98

1.2

1.7

1.52

9.72

nmol/l

—

Personal history of risk-factors, not elsewhere classified

2.18

0.98

1.2

1.7

1.52

10.77

nmol/l

—

Collagenous colitis

198

1.42

0.97

1.4

1.8

6.97

8.05

nmol/l

0.08

156

Bitten or struck by other mammals

292

1.34

0.97

1.8

1.7

1.97

3.61

nmol/l

0.82

223

Other predominantly sexually transmitted diseases, not elsewhere classified

468

1.26

0.97

1.3

1.7

2.89

2.80

nmol/l

0.02

375

Family history of malignant neoplasm

275

1.35

0.97

1.7

3.06

3.72

nmol/l

0.24

210

Excessive attrition of teeth

201

1760

1.13

0.96

1.5

1.6

5.60

7.66

nmol/l

0.21

163

1446

Other congenital malformations of tongue, mouth and pharynx

0.00

0.96

0.0

1.6

—

1.18

—

Other specified/unspecified hearing loss

157

1.47

0.96

1.4

1.7

1.29

7.60

nmol/l

1.46

134

Superficial injury of wrist and hand

541

1.24

0.95

1.5

1.6

2.41

7.61

nmol/l

0.57

430

Azathioprine

337

1.31

0.95

1.8

1.7

4.87

12.83

nmol/l

0.51

263

Mixed disorders of conduct and emotions

1.77

0.94

2.1

1.8

1.13

1.58

nmol/l

—

Habit and impulse disorders

2.23

0.93

1.5

1.6

2.52

0.86

nmol/l

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

109

1.56

0.93

2.0

2.1

3.10

7.39

nmol/l

1.06

Congenital malformations of the circulatory system

328

1.30

0.93

1.4

1.7

2.14

5.55

nmol/l

1.25

257

Exclusion endpoint for supernumerary teeth

2.16

0.91

1.3

1.6

2.48

0.98

nmol/l

—

Malignant neoplasm of rectosigmoid junction, including Hilmo

2.15

0.91

1.2

2.3

14.85

9.95

nmol/l

—

Other viral diseases

741

1.20

0.91

1.7

5.39

7.05

nmol/l

0.16

600

Herpesviral [herpes simplex] infections

261

1.34

0.91

1.7

8.10

6.16

nmol/l

0.13

202

Peripheral artery operations in Hilmo

184

1.41

0.91

1.7

1.8

2.27

8.08

nmol/l

1.48

159

Other sexually transmitted chlamydial diseases, including avohilmo

291

0.69

0.91

1.7

1.6

5.36

2.33

nmol/l

0.51

227

Pediculosis, acariasis and other infestations

118

1.53

0.90

1.1

1.8

4.03

3.74

nmol/l

0.05

ILD medications: azathioprine

340

1.30

0.90

1.8

1.6

4.87

11.95

nmol/l

0.45

268

Erosion of teeth , including avohilmo

728

1.20

0.89

1.5

1.7

1.88

15.01

nmol/l

0.97

588

Postmenopausal atrophic vaginitis

309

0.77

0.88

2.0

1.7

1.93

4.54

nmol/l

2.05

273

Nonsuppurative otitis media

552

1.21

0.88

2.2

1.6

10.35

4.39

nmol/l

0.50

437

Degeneration of macula and posterior pole

108

710

1.17

0.87

1.6

5.03

5.53

nmol/l

0.09

604

Ptosis of eyelid

220

1.37

0.87

1.7

3.30

7.02

nmol/l

0.62

187

Other otitis externa (chronic)

144

1.46

0.87

1.6

1.8

4.58

7.57

nmol/l

0.28

117

Childhood allergy (age < 16)

347

1.26

0.86

1.6

1.89

2.67

nmol/l

0.41

265

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

585

1.22

0.86

1.4

1.6

2.56

nmol/l

0.00

468

Lichen planus

264

1.33

0.85

1.7

1.8

4.46

6.38

nmol/l

0.31

221

Hallux rigidus

265

1.32

0.84

1.3

1.6

2.90

4.42

nmol/l

0.30

221

Coxarthrosis, primary, with hip surgery

107

850

1.17

0.84

1.6

3.95

7.78

nmol/l

0.69

722

Other respiratory diseases principally affecting the interstitium

318

1.29

0.83

1.7

8.39

7.34

nmol/l

0.07

272

Chronic suppurative otitis media

129

1.48

0.83

1.3

2.0

3.03

4.88

nmol/l

0.44

104

Rheumatoid arthritis, including avohilmo

101

863

1.17

0.83

1.6

2.36

4.48

nmol/l

1.63

718

Type 1 diabetes, definitions combined

196

1.38

0.82

1.4

1.7

1.60

2.89

nmol/l

0.57

148

Isolated proteinuria

1.74

0.82

1.6

1.7

17.00

5.95

nmol/l

—

Benign neoplasm: Skin of upper limb, including shoulder

1.88

0.82

1.0

2.0

1.22

6.89

nmol/l

—

Gonococcal infection, including avohilmo

1.65

0.81

1.1

1.9

1.18

6.27

nmol/l

1.08

Melanocytic naevi

819

1.17

0.81

1.5

1.7

1.84

7.58

nmol/l

1.20

668

Medical treatment for female infertility

620

1.20

0.81

1.6

1.7

1.45

11.13

nmol/l

0.57

499

Pregnancy, childbirth and the puerperium

492

0.84

0.80

1.8

1.6

6.63

2.86

nmol/l

0.72

400

Use of fingolimod

0.00

0.79

0.0

2.4

—

1.20

—

Colitis, primary sclerosing

0.00

0.79

0.0

1.7

—

9.31

—

Other disorders of prostate

1.82

0.79

1.2

1.7

1.58

4.42

nmol/l

—

Use of selegiline

1.67

0.78

2.9

1.8

6.79

13.19

nmol/l

0.40

Abnormal spermatozoa

187

0.64

0.78

1.1

1.6

2.23

8.96

nmol/l

1.49

167

Retinal detachment with retinal break

246

0.69

0.77

1.7

2.46

8.22

nmol/l

1.51

204

Postpartum haemorrhage

672

0.83

0.77

1.4

1.7

2.71

2.49

nmol/l

0.07

535

LSIL lesion of the vagina

1.77

0.76

2.0

2.3

1.80

6.80

nmol/l

—

Crushed, pushed or stepped on by crowd or human stampede

174

1.38

0.76

2.0

1.7

4.84

2.91

nmol/l

0.25

137

Anogenital herpesviral [herpes simplex] infection

157

1.40

0.76

1.4

1.7

1.40

3.05

nmol/l

0.64

120

Malignant neoplasm, without specification of site

1.77

0.76

2.7

2.1

2.85

11.23

nmol/l

—

Carcinoma in situ of cervix uteri

279

1.29

0.75

1.5

1.7

1.91

3.38

nmol/l

0.69

210

Diabetic retinopathy, strict definition

503

1.20

0.75

1.4

1.7

37.17

15.47

nmol/l

0.28

427

Acute pancreatitis (for exclusion)

413

1.24

0.75

1.7

1.6

4.01

12.36

nmol/l

0.76

342

Mental and behavioural disorders due to opioids

1.57

0.75

1.5

1.9

1.95

4.46

nmol/l

—

440

1.21

0.74

1.4

1.7

2.79

6.47

nmol/l

1.70

386

Excessive earwax

170

1377

1.12

0.74

1.7

1.6

4.36

5.71

nmol/l

0.22

139

1149

Gonarthrosis, primary, with knee surgery

140

962

1.13

0.73

1.6

2.58

7.42

nmol/l

1.18

120

817

Other embolism and thrombosis

254

1.30

0.73

1.4

1.7

2.78

7.93

nmol/l

1.31

208

Arthropathy in ulcerative colitis

2.01

0.73

2.2

1.8

3.40

9.19

nmol/l

—

Bullous pemphigoid

2.01

0.72

1.0

1.6

2.56

9.54

nmol/l

—

Chronic suppurative otitis media, including avohilmo

159

1.39

0.72

1.2

1.9

2.69

7.00

nmol/l

0.79

132

Other and unspecified corneal deformities and disorders

1.67

0.72

1.4

1.8

1.41

4.44

nmol/l

—

Malignant neoplasm, without specification of site, including Hilmo

1.67

0.72

2.0

2.2

2.28

9.73

nmol/l

—

Toxic liver disease

1.93

0.70

1.6

1.9

2.02

8.67

nmol/l

—

Primary open-angle glaucoma

550

1.19

0.70

1.6

2.79

6.05

nmol/l

1.47

478

Other and unspecified mononeuropathies of lower limb

1.71

0.70

1.6

2.0

1.77

5.53

nmol/l

—

Tooth eruption problems

394

1.23

0.70

1.5

1.7

1.30

2.60

nmol/l

1.14

311

Fibrosis and cirrhosis of liver

135

1.41

0.69

1.5

1.7

2.17

9.65

nmol/l

1.16

107

Postpartum hemorraghe, all women as controls

783

0.85

0.68

1.4

1.7

2.71

9.40

nmol/l

0.47

631

Other congenital malformations, including avohilmo

310

1.26

0.68

1.6

1.7

11.30

3.52

nmol/l

0.36

233

Nystagmus and other irregular eye movements

1.86

0.68

1.2

1.8

5.56

1.35

nmol/l

—

Type 1 diabetes, strict (exclude DM2)

195

1.33

0.68

1.4

1.7

1.64

2.89

nmol/l

0.54

148

Other hearing loss

494

1.20

0.67

1.8

1.6

5.76

5.88

nmol/l

0.01

422

Effects of foreign body entering through natural orifice

551

0.82

0.67

1.7

1.6

1.73

9.82

nmol/l

1.08

436

All dysplastic lesions of the cervix uteri, vagina or vulva

101

860

1.15

0.67

1.7

1.83

9.12

nmol/l

0.61

697

Enteropathic arthropathies

1.63

0.67

2.1

1.7

2.84

2.54

nmol/l

—

Other disorders of bone density and structure

1.63

0.67

2.0

1.8

1.56

1.78

nmol/l

—

ILD medications: immunosuppressive drugs

190

1560

1.10

0.66

1.6

4.59

5.10

nmol/l

0.10

155

1309

Xerosis cutis

1.79

0.66

1.2

1.7

3.36

8.31

nmol/l

—

Malignant neoplasm of bone and articular cartilage, including Hilmo

1.79

0.66

1.0

2.3

1.70

9.22

nmol/l

—

Carcinoma in situ of skin

154

1.37

0.65

1.5

1.7

1.94

9.47

nmol/l

1.61

133

Impacted teeth

503

1.18

0.64

1.3

1.7

1.68

2.83

nmol/l

0.81

397

Benign neoplasm: Brain, supratentorial

1.73

0.64

1.6

1.8

3.40

7.72

nmol/l

—

Other osteochondropathies

146

1.37

0.63

1.3

1.7

2.55

3.26

nmol/l

0.17

119

LSIL lesion of the cervix uteri, vagina or vulva

378

1.22

0.62

1.5

1.7

1.86

3.07

nmol/l

0.91

300

Congenital malformations and deformations of the musculoskeletal system

224

1.29

0.62

1.4

1.8

2.37

3.77

nmol/l

0.52

167

Open wound of wrist and hand

126

1085

1.12

0.62

1.7

1.6

7.07

5.93

nmol/l

0.10

106

892

Budesonide

333

1.23

0.62

1.5

1.7

2.62

5.52

nmol/l

1.00

266

Premature rupture of membranes

497

0.84

0.62

2.1

1.6

1.79

14.05

nmol/l

0.59

402

Congenital malformations of the respiratory system

1.67

0.61

1.0

2.0

0.96

7.71

nmol/l

—

Seropositive rheumatoid arthritis, wide

563

1.17

0.61

1.6

1.7

1.95

5.59

nmol/l

2.43

460

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

554

1.17

0.60

1.6

1.7

1.95

5.63

nmol/l

2.43

454

Obstructive hydrocephalus

0.00

0.60

0.0

1.7

—

11.44

—

Congenital malformations of genital organs

234

1.28

0.60

1.3

1.7

2.94

3.75

nmol/l

0.21

173

Superficial injury of head

526

1.18

0.60

1.4

1.7

3.22

9.10

nmol/l

0.64

425

Benign neoplasm: Sigmoid colon

380

1.21

0.60

1.7

3.24

7.21

nmol/l

1.18

318

Abnormal findings on examination of urine, without diagnosis

1.50

0.59

2.7

1.9

12.14

4.16

nmol/l

0.44

Contraceptive management

109

859

0.89

0.59

1.6

1.47

6.37

nmol/l

1.05

700

Benign neoplasm: Skin of lower limb, including hip

1.54

0.59

1.6

1.8

2.31

5.74

nmol/l

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

0.00

0.59

0.0

1.8

—

10.54

—

Benign neoplasm: Skin of trunk

1.53

0.59

1.4

1.9

2.72

4.69

nmol/l

0.30

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

369

1.21

0.59

1.7

2.31

5.11

nmol/l

1.07

290

Neonatal jaundice from other and unspecified causes

0.00

0.59

0.0

2.3

—

1.44

—

Transplanted organ and tissue status

192

1.30

0.59

1.6

1.9

6.83

7.68

nmol/l

0.08

158

Benign neoplasm: Caecum

201

1.30

0.58

1.3

1.7

1.30

9.97

nmol/l

2.08

168

Other sexually transmitted chlamydial diseases

162

0.68

0.58

1.5

1.6

3.08

3.09

nmol/l

—

123

Any death

155

980

1.11

0.58

1.7

1.6

13.95

5.78

nmol/l

1.10

133

826

Other obstetric trauma

150

0.67

0.58

1.8

1.6

21.94

2.51

nmol/l

—

109

Optic neuritis

1.46

0.58

1.9

1.74

4.28

nmol/l

—

Glaucoma-related operations

1.46

0.58

1.5

1.9

1.52

7.23

nmol/l

1.35

Toxic effects of substances chiefly nonmedicinal as to source

255

1.26

0.58

1.6

1.7

2.57

6.08

nmol/l

0.77

201

Other disorders of breast

346

1.22

0.57

1.2

1.7

2.26

3.44

nmol/l

0.65

272

Pleural effusion

264

0.76

0.57

1.6

1.7

5.74

8.28

nmol/l

0.31

223

Single delivery by caesarean section

420

0.85

0.56

1.3

1.6

1.58

2.84

nmol/l

0.75

334

Primary coxarthrosis, bilateral

549

1.17

0.56

1.7

3.78

5.33

nmol/l

0.47

473

Injuries involving multiple body regions

1.51

0.56

2.1

1.7

2.28

4.25

nmol/l

0.33

Other/unspecified seropositive rheumatoid arthritis

559

1.16

0.56

1.6

1.95

5.60

nmol/l

2.43

458

Crossbite

162

1.31

0.55

1.7

1.8

5.42

3.28

nmol/l

0.26

128

Presence of other devices

441

1.18

0.55

2.0

1.7

3.68

6.73

nmol/l

0.68

373

Embedded and impacted teeth

658

1.14

0.55

1.4

1.7

1.67

3.06

nmol/l

1.39

518

Malignant neoplasm of breast, HER-negative

413

1.19

0.55

1.4

1.7

4.01

3.82

nmol/l

0.04

333

Any dementia, excluding more controls

409

1.16

0.54

1.4

1.6

5.92

5.47

nmol/l

0.05

349

Desensitization to allergens

125

1.36

0.53

2.6

1.7

1.34

3.46

nmol/l

0.65

Calculus of lower urinary tract

1.49

0.53

2.2

1.6

1.85

13.18

nmol/l

1.08

Colectomy operation

331

1.21

0.53

1.6

1.7

3.19

7.70

nmol/l

1.45

275

Unspecified chronic bronchitis

1.54

0.53

1.0

1.8

9.73

6.28

nmol/l

—

Alcoholic liver disease

178

1.29

0.52

1.2

1.7

2.59

8.02

nmol/l

1.16

152

Medical abortion

183

1079

0.92

0.52

1.8

1.7

3.61

7.93

nmol/l

0.40

157

882

Gonococcal infection

1.52

0.52

1.1

1.9

1.31

6.53

nmol/l

—

Allergic urticaria

196

1.28

0.52

1.4

1.6

1.85

3.81

nmol/l

0.83

151

Laparoscopic right hemicolectomy

100

1.40

0.51

1.6

1.8

1.35

10.35

nmol/l

1.29

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

294

1.22

0.51

1.4

1.7

2.09

3.58

nmol/l

0.73

221

HSIL lesion of the cervix uteri

527

1.16

0.51

2.0

1.6

1.84

13.08

nmol/l

0.57

427

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

162

1.30

0.50

1.3

1.8

1.58

2.63

nmol/l

0.63

122

Wet age-related macular degeneration

269

1.22

0.49

1.4

1.6

3.09

8.05

nmol/l

1.25

235

Delivery, wide proxy

100

593

0.89

0.49

1.8

1.6

3.75

3.10

nmol/l

0.22

486

Prurigo nodularis

1.56

0.49

1.0

2.1

1.40

8.93

nmol/l

—

Other and unspecified disorders of vitreous body

109

960

1.11

0.49

1.5

1.7

2.83

4.89

nmol/l

1.33

805

Colonic or urogenital fistula

623

1.14

0.49

1.3

1.7

1.81

9.09

nmol/l

1.13

502

5-aminosalicylic acid

492

1.16

0.49

1.6

1.7

3.31

10.24

nmol/l

0.74

400

Malignant neoplasm of breast, ER-negative, including Hilmo

443

1.16

0.48

1.4

1.7

3.88

3.85

nmol/l

0.01

357

Raynaud syndrome

217

1.25

0.48

1.5

1.7

4.32

5.75

nmol/l

0.16

167

Lichen planus, including avohilmo

419

1.17

0.47

1.6

6.23

6.22

nmol/l

0.00

338

Acute appendicitis, with complications

419

1.17

0.47

1.2

1.6

7.37

12.31

nmol/l

0.28

335

Endometriosis diagnosis and infertility diagnosis occurring together

281

1.21

0.47

1.4

1.7

1.99

3.45

nmol/l

0.68

223

Malignant neoplasm of colon, including Hilmo

298

1.20

0.47

1.6

1.8

4.49

4.51

nmol/l

0.01

250

Pneumonia derived septicemia

1.46

0.46

1.6

1.5

1.67

5.05

nmol/l

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

504

1.15

0.46

1.7

5.74

5.72

nmol/l

0.00

415

Examination and encounter for administrative purposes

120

1.33

0.46

1.5

1.58

7.83

nmol/l

1.00

101

Non-Hodgkin lymphoma, all

1.43

0.46

2.0

2.1

3.03

8.05

nmol/l

—

Injury of muscle and tendon at hip and thigh level

210

1.24

0.45

1.6

1.7

2.06

7.24

nmol/l

1.23

167

HSIL lesion of the cervix uteri, vagina or vulva

581

1.14

0.44

1.9

1.6

1.82

12.04

nmol/l

0.58

475

Benign mammary dysplasia

311

1.19

0.44

1.8

1.7

1.69

4.03

nmol/l

2.01

248

Covid-19 suspected case

544

1.14

0.44

1.8

1.7

86.98

4.29

nmol/l

0.47

434

Benign neoplasm: Cranial nerves

1.37

0.44

1.3

2.0

0.96

5.01

nmol/l

—

Acute posthaemorrhagic anaemia

1.37

0.44

1.1

1.9

1.43

5.12

nmol/l

—

malignant neoplasm of female genital organs, including Hilmo

358

1.17

0.44

1.4

1.8

7.15

4.16

nmol/l

0.24

288

Struck by thrown, projected or falling objec

104

1.35

0.43

1.5

1.7

0.77

3.66

nmol/l

0.93

Chronic mastoiditis

1.62

0.43

5.8

1.9

2.40

7.19

nmol/l

—

Pregnancy with abortive outcome

195

1091

0.93

0.43

1.7

3.48

7.87

nmol/l

0.42

157

890

Primary_lymphoid and hematopoietic malignant neoplasms

471

1.15

0.42

1.6

1.7

2.03

6.41

nmol/l

2.56

393

Pyoderma

1.57

0.42

1.4

2.3

13.68

7.52

nmol/l

—

Other and unspecified abdominal hernia

1.43

0.41

1.4

1.8

4.84

7.20

nmol/l

—

Other disorders of veins

113

1015

1.10

0.41

1.5

1.6

2.19

11.43

nmol/l

0.99

847

Spermatocele

1.36

0.41

2.2

1.6

1.65

4.32

nmol/l

1.88

Other congenital malformations of heart

0.00

0.41

0.0

1.8

—

18.38

—

Varicose veins

159

1112

1.08

0.41

1.5

1.6

4.07

6.17

nmol/l

0.39

127

936

Mandibular retrognathia AND surgery (BSSO)

1.36

0.41

1.3

1.9

0.73

2.41

nmol/l

—

Haemolytic anaemias

1.36

0.41

1.6

1.9

1.70

4.41

nmol/l

—

Molar incisor enamel hypoplasia, with caries

0.00

0.40

0.0

2.7

—

1.32

—

Hypoplasia of dental enamel

0.00

0.40

0.0

2.6

—

1.33

—

Malignant neoplasm of skin

110

679

1.10

0.40

1.5

1.8

2.15

7.00

nmol/l

0.75

558

Other and unspecified types of non-Hodgkin lymphoma, hilmo

1.31

0.39

1.0

1.9

2.56

4.54

nmol/l

—

Malignant neoplasm of mesothelium and soft tissue

1.31

0.39

1.1

2.3

1.65

9.51

nmol/l

—

Diabetic retinopathy

126

718

1.09

0.39

1.4

1.7

21.28

12.01

nmol/l

0.20

107

610

L02BX Other hormone antagonists and related agents

1.41

0.39

1.2

1.8

20.66

13.86

nmol/l

—

Artificial joint operation, meniscal resection

242

1457

1.06

0.39

1.7

1.6

2.55

5.83

nmol/l

1.20

204

1213

Scarlet fever, including avohilmo

0.00

0.39

0.0

1.9

—

12.62

—

Colitis, primary sclerosing, strict definition

0.00

0.39

0.0

1.7

—

1.15

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

397

1.15

0.39

1.6

1.7

2.31

5.19

nmol/l

1.20

311

Achilles tendinitis

187

1.23

0.38

1.7

1.6

8.21

6.44

nmol/l

0.09

152

Dislocation, sprain and strain of joints and ligaments of thorax

1.35

0.38

1.3

1.8

2.30

4.55

nmol/l

—

Infectious mononucleosis

225

0.80

0.37

1.4

1.6

13.82

2.68

nmol/l

0.41

177

Infectious mononucleosis, including avohilmo

225

0.80

0.37

1.4

1.6

13.82

2.68

nmol/l

0.41

177

Maternal care for known or suspected abnormality of pelvic organs

564

1.10

0.37

1.8

1.6

1.33

12.73

nmol/l

0.64

460

Mixed conductive and sensorineural hearing loss

234

1.20

0.37

2.5

1.7

3.90

8.23

nmol/l

0.96

200

Ulcerative colitis

581

1.12

0.37

1.5

1.6

3.34

9.04

nmol/l

0.70

470

Inflammatory bowel disease

781

1.10

0.37

1.5

1.6

2.98

7.46

nmol/l

0.75

631

Redundant prepuce, phimosis and paraphimosis

341

1.15

0.36

1.5

1.6

69.53

4.21

nmol/l

0.51

288

Retinal detachments and breaks

716

1.10

0.36

1.3

1.7

4.60

5.09

nmol/l

0.07

598

Other and unspecified injuries of wrist and hand

0.66

0.35

1.6

1.9

1.40

1.70

nmol/l

—

ILD, hospital admissions

263

1.18

0.35

1.5

1.7

11.05

7.95

nmol/l

0.16

222

Benign neoplasm: Anus and anal canal

1.43

0.35

1.3

1.8

3.65

5.86

nmol/l

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

122

0.74

0.35

1.3

1.7

2.86

6.01

nmol/l

—

Primary open-angle glaucoma, strict

478

1.13

0.35

1.6

1.7

2.80

6.33

nmol/l

1.32

415

Degenerative diseases of the nervous system

429

0.89

0.34

1.4

1.7

6.89

6.51

nmol/l

0.04

367

Disorders of acoustic nerve

1.37

0.34

1.3

1.8

0.88

5.67

nmol/l

—

Colorectal cancer, including Hilmo

430

1.13

0.34

1.5

1.8

4.91

9.16

nmol/l

0.35

362

Other benign neoplasms of uterus

100

1.30

0.33

1.5

1.8

1.22

6.92

nmol/l

—

ILD, hospital admissions 1, main diag only

237

1.18

0.33

1.6

1.7

11.94

8.47

nmol/l

0.17

202

Contusion of other and unspecified parts of foot

127

1.26

0.33

1.3

1.7

0.97

3.42

nmol/l

—

Hydrocephalus

133

0.75

0.33

1.6

1.7

1.62

8.91

nmol/l

—

113

Interstitial lung disease endpoints

265

1.17

0.33

1.5

1.7

11.05

7.89

nmol/l

0.17

224

Interstitial lung disease

265

1.17

0.33

1.5

1.7

11.05

7.89

nmol/l

0.17

224

Peritonsillar abscess

472

1.12

0.33

1.5

1.6

2.37

20.13

nmol/l

0.86

402

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

273

1641

1.05

0.33

1.6

4.37

8.25

nmol/l

0.53

223

1374

Abrasion of teeth

100

922

1.09

0.33

1.9

1.6

1.45

12.78

nmol/l

1.14

762

Other interstitial pulmonary diseases

266

1.17

0.32

1.5

1.7

11.05

7.87

nmol/l

0.17

225

Atopic conjunctivitis

1.31

0.31

3.6

1.7

1.68

5.93

nmol/l

0.85

Ectopic pregnancy

455

1.12

0.31

1.2

1.8

1.56

2.62

nmol/l

1.79

367

Pedestrian injured in collision with pedal cycle

1.35

0.31

1.4

1.9

2.37

4.95

nmol/l

—

Pneumococcal septicemia

1.35

0.31

1.6

1.67

4.90

nmol/l

—

Overjet

1.32

0.30

1.4

1.7

3.99

1.42

nmol/l

—

malignant neoplasm of female genital organs

326

1.14

0.30

1.4

1.8

8.26

4.26

nmol/l

0.27

262

Malignant neoplasm of brain

1.30

0.30

1.4

2.2

1.00

5.29

nmol/l

—

Seborrhoeic keratosis

514

1.11

0.30

2.3

1.6

3.59

6.12

nmol/l

0.68

426

Exposure to other and unspecified inanimate mechanical forces

166

1.21

0.29

1.3

1.8

1.23

3.19

nmol/l

0.93

132

Other specified disorders of external ear

1.25

0.29

3.9

1.9

1.76

11.54

nmol/l

—

Inguinal hernia

136

847

1.07

0.29

1.6

4.03

7.17

nmol/l

0.53

119

701

Use of memantine

329

0.88

0.28

1.5

1.6

7.34

7.58

nmol/l

0.02

285

Use of other anti-dementia drugs

329

0.88

0.28

1.5

1.6

7.34

7.58

nmol/l

0.02

285

Long labour

647

0.92

0.28

2.0

1.7

73.79

2.56

nmol/l

0.48

519

Non-allergic asthma

167

1.20

0.28

1.3

1.7

9.59

6.84

nmol/l

0.11

132

Separation of retinal layers (serosa)

1.32

0.28

2.6

1.9

13.15

1.51

nmol/l

—

Residual foreign body in soft tissue

1.28

0.28

1.4

1.5

2.40

8.42

nmol/l

0.65

All dysplastic lesions of the cervix uteri

774

1.08

0.27

1.8

1.7

1.86

9.47

nmol/l

0.56

628

Femoral hernia

1.25

0.27

1.3

1.9

13.69

5.10

nmol/l

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

1.23

0.27

1.6

2.2

1.60

8.82

nmol/l

—

Other vitreous opacities

0.68

0.26

1.2

1.9

4.38

6.00

nmol/l

—

Intermittent heterotropia

141

1.20

0.25

1.2

1.8

14.47

3.25

nmol/l

0.37

110

Malignant neoplasm of eye, brain and central nervous system

1.22

0.25

1.6

2.0

1.24

6.89

nmol/l

—

UC patients in KELA-register (code 208), prior to 1994

0.74

0.24

2.0

1.8

5.08

5.82

nmol/l

—

Ménière disease

189

1.16

0.24

1.6

1.8

1.89

7.87

nmol/l

1.52

156

Other abnormal products of conception

112

691

1.06

0.23

1.7

1.60

10.45

nmol/l

0.58

548

L04AA Selective immunosuppressants

527

0.91

0.23

1.5

1.7

2.58

9.82

nmol/l

0.88

426

Intrahepatic Cholestasis of Pregnancy (ICP)

180

1.17

0.23

1.3

1.7

1.58

2.42

nmol/l

0.52

133

Etanercept

158

0.82

0.23

2.0

1.7

1.64

4.19

nmol/l

—

122

Cerebral palsy

1.32

0.23

1.0

1.7

0.88

1.66

nmol/l

—

Inguinal hernia, unilateral

1.32

0.23

1.2

1.8

20.68

6.43

nmol/l

—

Inguinal of femoral hernia, unilateral

1.32

0.23

1.2

1.8

20.68

6.43

nmol/l

—

Femoral hernia, unilateral

1.32

0.23

1.2

1.8

20.68

6.43

nmol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

190

1.16

0.23

1.3

1.7

1.52

2.91

nmol/l

1.03

142

L01XE Protein kinase inhibitors

0.77

0.22

1.4

2.0

15.36

5.80

nmol/l

—

Burn and corrosion of hip and lower limb, except ankle and foot

1.25

0.22

1.0

1.5

3.16

6.27

nmol/l

—

Superficial injury of thorax

333

1.11

0.22

1.5

1.6

3.34

7.46

nmol/l

1.01

262

Dementia

544

1.07

0.21

1.5

1.7

5.14

6.40

nmol/l

0.21

472

Assault by unspecified means

1.16

0.21

1.2

1.7

2.24

1.94

nmol/l

—

Carcinoma in situ of skin of trunk

1.16

0.21

1.0

1.8

2.40

6.06

nmol/l

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

429

0.91

0.21

1.6

3.96

10.48

nmol/l

0.54

336

Malignant neoplasm of skin, including Hilmo

116

736

1.06

0.20

1.4

1.8

2.01

6.65

nmol/l

0.79

102

605

Adalimumab

249

1.13

0.20

1.4

1.7

3.91

3.78

nmol/l

0.02

192

Glucosamine medication

100

754

1.06

0.20

1.7

1.6

3.42

5.05

nmol/l

0.69

643

Pregnancy examination and test

362

0.92

0.20

2.1

1.6

1.70

2.23

nmol/l

0.34

284

Unspecific neurodegenerative disorder

512

0.94

0.19

1.6

1.7

5.85

6.18

nmol/l

0.04

442

Benign neoplasm: Parotid gland

154

0.84

0.19

1.4

1.8

2.75

8.29

nmol/l

0.99

133

Otitis media, unspecified

266

1.11

0.18

2.4

1.7

3.51

2.94

nmol/l

0.11

205

Malignant neoplasm of brain, including Hilmo

1.24

0.18

1.3

2.0

0.94

6.94

nmol/l

—

Maternal care for known or suspected malpresentation of fetus

451

0.93

0.18

1.7

1.6

1.72

14.65

nmol/l

0.56

366

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

393

0.92

0.17

1.6

4.17

11.31

nmol/l

0.54

306

Biological medication for rheuma

455

1.08

0.17

1.7

2.95

9.84

nmol/l

0.64

359

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

291

1.10

0.17

1.2

1.6

4.86

7.82

nmol/l

0.43

247

Prepatellar bursitis

1.11

0.17

1.0

1.8

1.10

11.54

nmol/l

—

L02BG Aromatase inhibitors

690

1.06

0.16

1.4

1.6

1.77

3.52

nmol/l

2.75

553

Diffuse large B-cell lymphoma, including Hilmo

1.14

0.16

1.6

2.1

2.31

8.34

nmol/l

—

Diffuse large B-cell lymphoma

1.14

0.16

1.6

2.1

2.31

8.34

nmol/l

—

Diffuse large B-cell lymphoma, helper endpoint

1.14

0.16

1.6

2.1

2.31

8.34

nmol/l

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

1.11

0.16

3.1

1.8

1.48

4.76

nmol/l

—

Other menopausal disorders

346

1.06

0.16

1.7

2.53

4.13

nmol/l

0.74

307

Other (seronegative) rheumatoid arthritis, wide

399

1.08

0.15

1.9

1.6

2.74

6.52

nmol/l

1.17

317

Fracture of forearm

155

1343

1.04

0.15

1.5

1.6

6.80

4.96

nmol/l

0.23

130

1100

Bilateral sagittal split ramus osteotomy operation

1.15

0.15

1.2

1.8

1.02

2.13

nmol/l

—

Obstructed labour due to maternal pelvic abnormality

381

1.08

0.14

1.6

1.7

1.99

4.04

nmol/l

1.61

310

Poor fetal growth

362

1.08

0.14

1.4

1.7

1.75

1.87

nmol/l

0.07

283

Ethmoidectomy

285

1.09

0.14

1.6

1.7

4.87

6.13

nmol/l

0.18

227

Malignant neoplasm of breast

108

725

0.96

0.14

1.4

1.7

3.04

3.25

nmol/l

0.09

586

Malignant neoplasm of breast, HER2-negative

108

725

0.96

0.13

1.4

1.7

3.04

3.25

nmol/l

0.09

586

Benign neoplasm of major salivary glands

191

0.89

0.13

1.4

1.7

2.44

7.30

nmol/l

1.08

160

Fitting and adjustment of other devices

586

1.05

0.13

1.9

1.6

4.51

5.04

nmol/l

0.10

497

FESS (DNB20)

277

1.08

0.12

1.6

1.7

3.64

6.32

nmol/l

0.50

219

Colorectal cancer

388

1.06

0.12

1.5

1.8

5.16

3.94

nmol/l

0.31

331

Caries of enamel

293

1877

1.02

0.11

1.7

1.6

1.92

8.18

nmol/l

1.36

236

1557

Undefined dementia

126

0.88

0.11

1.5

1.7

2.40

8.56

nmol/l

1.02

107

Speech therapy

572

1.05

0.11

2.2

1.7

3.87

5.68

nmol/l

0.38

472

Malignant neoplasm of breast, including Hilmo

111

735

0.97

0.11

1.4

1.7

3.03

10.49

nmol/l

0.51

596

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

700

1.04

0.11

1.6

4.08

7.76

nmol/l

0.44

559

Ulcerative colitis (strict definition, require KELA)

404

0.94

0.11

1.6

4.07

11.06

nmol/l

0.54

314

Malignant neoplasm of breast, HER2-negative, including Hilmo

111

735

0.97

0.11

1.4

1.7

3.03

10.49

nmol/l

0.51

596

Spontaneous abortion

139

958

0.97

0.11

1.6

1.7

1.56

8.33

nmol/l

0.65

112

785

Lichen sclerosus et atrophicus

250

1.08

0.11

1.2

1.6

4.64

4.47

nmol/l

0.02

199

DVT of lower extremities

373

0.94

0.11

2.0

1.7

3.58

6.81

nmol/l

0.72

311

L04AX Other immunosuppressants

153

1489

1.03

0.10

1.7

1.6

4.61

8.85

nmol/l

0.51

125

1236

Retained placenta and membranes, without haemorrhage

311

0.93

0.10

3.0

1.7

9.83

3.46

nmol/l

0.36

251

Phlebitis and thrombophlebitis (not including DVT)

495

0.95

0.10

1.7

9.49

10.51

nmol/l

0.05

408

Sequelae of infectious and parasitic diseases, including avohilmo

146

0.89

0.10

2.0

1.9

3.04

3.75

nmol/l

—

115

Seropositive rheumatoid arthritis, strict definition

321

0.93

0.10

1.8

1.7

2.14

6.26

nmol/l

1.64

258

Medicines for HER+ breast cancer

848

0.97

0.10

1.4

1.7

2.05

3.32

nmol/l

1.84

689

Infliximab

1.14

0.10

3.6

1.9

1.68

1.78

nmol/l

—

Other and unspecified intracranial injuries

1.06

0.09

1.0

1.7

2.04

5.68

nmol/l

—

Suppurative otitis media, unspecified

1.04

0.09

1.8

1.9

2.48

5.67

nmol/l

—

Impacted cerumen

217

0.92

0.09

2.4

1.7

2.82

9.43

nmol/l

1.51

182

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

116

1.12

0.09

1.4

1.8

1.17

5.97

nmol/l

1.68

Other specified/unspecified inflammatory spondylopathies

1.13

0.09

1.6

1.5

1.98

2.27

nmol/l

0.12

Nasal polyp

370

0.95

0.09

1.6

1.7

4.28

12.69

nmol/l

0.68

317

Use of ropinirole

0.82

0.08

1.2

1.6

2.06

11.14

nmol/l

—

Disorders of eyelid in diseases classified elsewhere

0.83

0.08

1.6

2.0

29.32

4.93

nmol/l

—

Normal-pressure hydrocephalus

0.81

0.08

2.0

1.8

2.68

5.17

nmol/l

—

Benign neoplasm: Other and unspecified parts of mouth

0.79

0.08

1.2

1.9

2.40

4.92

nmol/l

—

ILD, hospital admission 2, with pulmonary infections

146

1.10

0.08

2.1

1.7

6.08

10.19

nmol/l

0.51

127

L04AC Interleukin inhibitors

154

0.91

0.08

1.8

2.58

4.10

nmol/l

—

126

Crohn disease

307

0.94

0.07

1.6

2.34

5.36

nmol/l

0.87

236

LSIL lesion of the cervix uteri

313

1.05

0.07

1.5

1.7

1.89

3.14

nmol/l

0.72

241

Any dementia

475

1.03

0.07

1.4

1.7

5.85

6.22

nmol/l

0.05

410

Maternal care related to the fetus and amniotic cavity and possible delivery problems

140

838

0.98

0.07

1.8

1.7

2.01

9.52

nmol/l

0.62

102

687

Lymphoid leukaemia

1.05

0.07

1.4

1.7

1.93

6.51

nmol/l

—

Postmenopausal bleeding

293

1.04

0.06

1.5

1.7

4.01

4.68

nmol/l

0.14

262

Basal cell carcinoma, including Hilmo

614

1.03

0.06

1.2

1.7

2.42

7.50

nmol/l

0.70

507

Sudden idiopathic hearing loss

187

1.07

0.06

1.6

1.7

1.70

8.70

nmol/l

1.54

162

Inflammatory bowel disease, strict (require KELA)

558

0.97

0.06

1.5

1.6

3.12

9.33

nmol/l

0.74

450

Ulcerative colitis (strict definition, all Crohn cases excluded)

345

0.96

0.06

1.7

1.6

3.97

5.42

nmol/l

0.26

265

Benign neoplasm: salivary glands, exclude unknown (D119)

172

0.93

0.06

1.4

1.7

2.54

7.79

nmol/l

1.06

146

Cholecystitis

247

1.05

0.05

1.5

1.7

2.13

8.16

nmol/l

1.75

210

Sequelae of infectious and parasitic diseases

141

0.92

0.05

2.0

1.8

3.04

3.52

nmol/l

—

112

Postpartum care and examination

336

1.03

0.04

1.5

1.6

5.30

2.29

nmol/l

0.33

263

Oral lichen planus, including avohilmo , including avohilmo

160

1.06

0.04

1.7

2.59

5.32

nmol/l

0.81

130

Unspecified abortion

119

0.92

0.04

1.3

1.7

3.37

3.45

nmol/l

0.01

Macular pucker

301

0.96

0.03

1.6

1.7

1.70

7.08

nmol/l

2.00

257

Postpartum hemorraghe, parous women as controls

580

0.98

0.03

1.4

1.7

2.71

11.75

nmol/l

0.47

462

Persons encountering health services in circumstances related to reproduction

172

1140

1.01

0.03

1.6

2.58

5.98

nmol/l

0.89

126

937

Benign neoplasm of other and unspecified female genital organs

1.09

0.03

2.1

1.9

20.30

6.26

nmol/l

—

Use of rivastigmine

230

1.04

0.03

1.6

1.7

8.58

9.04

nmol/l

0.02

197

Complications predominantly related to the puerperium

742

0.98

0.03

1.6

1.7

2.41

10.11

nmol/l

0.54

607

Methotrexate

281

1.03

0.02

1.8

1.7

1.34

6.04

nmol/l

1.79

226

Non-follicular lymphoma

158

0.95

0.02

1.6

1.8

2.29

11.47

nmol/l

1.62

136

Malignant neoplasm of breast, ER-positive, including Hilmo

603

0.99

0.02

1.4

1.7

2.04

3.35

nmol/l

1.45

486

Tumor necrosis factor alpha inhibitors

409

0.98

0.02

1.6

1.7

3.06

4.15

nmol/l

0.23

318

Erectile dysfunction

103

1.07

0.02

1.0

1.6

1.24

13.56

nmol/l

1.48

Puerperal sepsis

298

0.97

0.02

1.4

1.7

4.73

3.77

nmol/l

0.14

233

Second line medication for Crohn's disease

154

1548

0.99

0.01

1.6

4.58

8.58

nmol/l

0.49

126

1285

Malignant neoplasm of breast, HER-positive

602

0.99

0.01

1.4

1.7

2.04

3.35

nmol/l

1.45

485

Other malignant neoplasms of skin (=non-melanoma skin cancer)

603

0.99

0.01

1.2

1.8

2.54

3.69

nmol/l

0.64

497

Basal cell carcinoma

591

0.99

0.01

1.2

1.7

2.50

3.62

nmol/l

0.61

488

Glaucoma, exfoliation

164

1.04

0.00

1.6

2.63

11.97

nmol/l

1.64

135

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

214

1.03

0.00

1.3

1.7

1.52

4.06

nmol/l

1.22

162

Injury of muscle and tendon at lower leg level

304

1.02

0.00

1.5

1.6

4.79

15.01

nmol/l

0.63

246

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

642

1.00

0.00

1.3

1.7

2.20

7.27

nmol/l

0.74

529

Ulcerative colitis, NAS

327

1.01

0.00

1.5

1.6

4.31

5.16

nmol/l

0.14

255

Unspecified dementia

105

1.03

0.00

1.5

1.6

2.40

9.48

nmol/l

1.03

Other noninflammatory disorders of cervix uteri

1.01

0.00

1.2

1.7

1.82

7.03

nmol/l

—

Maternal care for other known or suspected fetal problems

520

1.00

0.00

1.6

1.39

12.90

nmol/l

0.58

423

Other and unspecified injuries of ankle and foot

1.04

0.00

1.2

1.8

1.33

3.79

nmol/l

—

Other peripheral vertigo

189

1.01

0.00

1.8

1.7

2.88

7.02

nmol/l

0.86

158

Infections of genitourinary tract in pregnancy

241

1.00

0.00

1.5

1.7

2.25

3.79

nmol/l

0.62

193

Myocardial infarction, unclassifiable

287

1.00

0.00

1.4

1.7

2.08

8.13

nmol/l

2.17

251

Antepartum haemorrhage, not elsewhere classified

244

0.98

0.00

2.0

1.5

1.33

25.20

nmol/l

0.54

194

Dementia, including avohilmo

597

1.00

0.00

1.5

1.6

5.05

6.09

nmol/l

0.17

514

IBD patients in KELA-register

541

1.00

0.00

1.5

1.6

3.12

9.45

nmol/l

0.73

436

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

113

0.97

0.00

1.8

2.03

4.07

nmol/l

—

Sequelae of other and unspecified infectious and parasitic diseases

113

0.97

0.00

1.8

2.03

4.07

nmol/l

—

Noise effects on inner ear

0.94

0.00

1.4

1.6

26.96

9.16

nmol/l

—

Colitis due to radiation

0.00

0.0

2.7

—

27.39

—

Malignant neoplasm of uterus, part unspecified, including Hilmo

0.00

0.0

1.8

—

21.11

—

Rhabdomyosarcoma, including Hilmo

0.00

0.0

2.0

—

32.70

—

Spinal instabilities

1.00

0.00

2.0

1.7

0.98

2.71

nmol/l

—

Absence of one kidney, including avohilmo

0.00

0.0

2.4

—

32.51

—

Bladder disorders in in diseases classified elsewhere

0.00

-0.00

0.0

1.6

—

32.64

—

Effects of other deprivation

0.00

-0.00

0.0

2.3

—

1.29

—

Burn and corrosion of wrist and hand

0.90

-0.00

2.2

1.6

1.33

4.55

nmol/l

—

Mental and behavioural disorders due to use of volatile solvents

0.00

-0.00

0.0

2.3

—

0.77

—

Lichenoid drug reaction

0.00

-0.00

0.0

2.0

—

33.00

—

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

0.00

-0.00

0.0

2.5

—

20.93

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

0.94

-0.00

1.3

1.9

2.50

6.95

nmol/l

—

Lichen planopilaris

0.00

-0.00

0.0

2.0

—

27.60

—

Onychogryphosis

0.00

-0.00

0.0

1.8

—

27.48

—

Chronic nephritic syndrome

0.94

-0.00

2.8

1.9

1.38

4.98

nmol/l

—

Apocrine sweat disorders, other sweat gland disorders

0.00

-0.00

0.0

2.4

—

23.82

—

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

0.00

-0.00

0.0

1.8

—

21.09

—

Corneal pigmentations and deposits

0.00

-0.00

0.0

2.6

—

1.19

—

Alport

0.00

-0.00

0.0

2.6

—

1.93

—

Other/unspecified crystal arthropathies

0.00

-0.00

0.0

1.8

—

21.06

—

Congenital deformities of feet

0.96

-0.00

1.4

1.8

1.88

5.19

nmol/l

—

Other obstructive and reflux uropathy

0.93

-0.00

2.3

1.9

2.10

1.81

nmol/l

—

Benign neoplasm: Long bones of lower limb

1.01

-0.00

1.7

1.8

1.84

4.66

nmol/l

—

Burns and corrosions confined to eye and internal organs

0.93

-0.00

1.6

1.7

2.62

5.01

nmol/l

—

Other and unspecified disease of Bartholin gland

0.85

-0.00

1.6

2.2

1.88

6.40

nmol/l

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

-0.00

0.0

2.2

—

0.91

—

Nezelof syndrome

0.00

-0.00

0.0

1.6

—

32.60

—

Hypertensive encephalopathy

0.00

-0.00

0.0

2.0

—

32.84

—

Hereditary sideroblastic anaemia

0.00

-0.00

0.0

2.4

—

32.71

—

Moderate visual impairment, monocular

0.00

-0.00

0.0

2.6

—

32.55

—

Lipodystrophy, not elsewhere classified

0.00

-0.00

0.0

2.6

—

1.27

—

Mechanical strabismus

0.00

-0.00

0.0

2.2

—

32.84

—

Otorrhoea

0.00

-0.00

0.0

2.8

—

1.97

—

Lichen simplex chronicus

0.98

-0.00

1.2

1.9

0.88

7.00

nmol/l

—

Benign neoplasm: Skin, unspecified

0.90

-0.00

2.0

1.8

2.33

4.24

nmol/l

—

Nightmares

0.00

-0.00

0.0

2.6

—

32.55

—

Changes in corneal membranes

0.00

-0.00

0.0

2.7

—

27.69

—

Renal agenesis and other reduction defects of kidney, including avohilmo

0.00

-0.00

0.0

2.1

—

20.58

—

Acquired pure red cell aplasia [erythroblastopenia]

0.00

-0.00

0.0

2.6

—

32.59

—

Follow-up care involving plastic surgery

0.97

-0.00

1.1

1.8

3.56

3.70

nmol/l

—

Oral lichen planus

1.00

-0.00

1.5

2.0

3.08

4.67

nmol/l

—

Other congenital malformations of face and neck

0.96

-0.00

1.0

2.1

0.84

5.49

nmol/l

—

Other mycoses, not elsewhere classified/unspecified

0.00

-0.00

0.0

2.3

—

1.09

—

Renal agenesis and other reduction defects of kidney

0.00

-0.00

0.0

2.1

—

20.58

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cortisol [Moles/volume] in Saliva (oral fluid)

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS